Analyte monitoring system with audible feedback

Information

  • Patent Grant
  • 10729386
  • Patent Number
    10,729,386
  • Date Filed
    Friday, June 20, 2014
    9 years ago
  • Date Issued
    Tuesday, August 4, 2020
    3 years ago
Abstract
Described here are devices, systems, and methods for analyte measurement. The analyte measurement devices and systems may be configured to produce a prompt that may convey information, instructions and/or encouragement to a user. In some variations, analyte measurement devices may be configured to change a prompt based on the replacement or addition of components of/to the device. In some instances, a prompt may be an auditory prompt and/or a visual prompt. In some variations, a system may comprise an analyte measurement device comprising a housing, a speaker, and a control unit. The housing may comprise a releasable housing portion comprising an identifier that is associated with a prompt. In some variations, a system may comprise an analyte measurement device and a skin that may releasably attach to the analyte measurement device and may comprise an identifier that is associated with a prompt.
Description
FIELD

The present invention relates to devices and methods for monitoring an analyte in a fluid sample (e.g. blood glucose) and providing visual and/or auditory feedback to a user of the devices.


BACKGROUND

Diabetes is a widespread condition, affecting millions worldwide. In the United States alone, an estimated 23.6 million people, or 7.8% of the population, have the condition. Diabetes accounts for an estimated $174 billion annually in direct and indirect medical costs. Depending on the type (Type 1, Type 2, and the like), diabetes may be associated with one or more symptoms such as fatigue, blurred vision, and unexplained weight loss, and may further be associated with one more complications such as hypoglycemia, hyperglycemia, ketoacidosis, neuropathy, and nephropathy.


To help delay or prevent these undesirable complications, it may be necessary for people with diabetes to monitor one or more blood analyte levels, such as blood glucose. Glucose testing allows a patient to ensure that his or her blood glucose is at a safe level, which in turn may help monitor the effectiveness of diet, medication, and exercise in controlling the patient's diabetes, and may also help reduce the risk of developing one or more diabetes-related conditions (e.g., blindness, kidney damage and nerve damage). Many of the currently available glucose meters, however, require numerous components and complicated steps to complete a test, and may result in a frustrating or otherwise negative user experience (which may reduce the likelihood of user compliance). As such, it may be desirable to produce safe and effective analyte concentration meters that may make sampling discrete and easier for the user.


BRIEF SUMMARY

Described here are analyte measurement devices and systems for providing feedback to a user. In some variations, an analyte measurement device may be configured to produce a plurality of auditory prompts to a user, and these prompts may convey information, instructions, and/or encouragement to a user. In some variations, the analyte measurement device may be able to change a set of auditory prompts outputted by the analyte measurement device. In some of these variations, a system may comprise an analyte measurement device comprising a housing, a speaker and a control unit. In these variations, the housing may comprise a releasable housing portion and the releasable housing portion may comprise an auditory identifier that is associated with an auditory prompt set. The control unit may be configured to detect the auditory identifier, set the auditory prompt set associated with the detected auditory identifier as an active prompt set, and instruct the speaker to output at least one auditory prompt from the active prompt set. In some variations, the control unit may comprise a processor and/or a memory unit.


In some variations the system may further comprise a plurality of releasable housing portions. In some of these variations, each of the releasable housing portions may be associated with an auditory prompt set comprising at least one auditory prompt that differs from at least one auditory prompt associated with the other releasable housing portions of the plurality of releasable housing portions. In some embodiments, the auditory prompt set associated with a releasable housing portion may be stored on the memory unit. In other embodiments, the auditory prompt set associated with the releasable housing portion may be stored on the releasable housing portion or on a server. The control unit may also comprise a speech unit and instructing the speaker to output at least one auditory prompt from the active prompt set may comprise transmitting a signal associated with the at least one auditory prompt from the speech unit to the speaker. In some variations, the analyte measurement devices described here may further comprise a display and/or a microphone. In some embodiments, the analyte measurement device may be an integrated meter. In some variations, the system may further comprise a cartridge.


In some embodiments, a system may comprise an analyte measurement device comprising a housing, a speaker, a control unit, and a skin. In these variations, the skin may be configured to releasably attach to the housing and may comprise an auditory identifier that may be associated with an auditory prompt set. The control unit may be configured to detect the auditory identifier, set the auditory prompt set associated with the detected auditory identifier as an active prompt set, and instruct the speaker to output at least one auditory prompt from the active prompt set. In some variations, the control unit may comprise a processor and/or a memory unit.


In some variations the system may further comprise a plurality of skins. In some of these variations, each skin may be associated with an auditory prompt set comprising at least one auditory prompt that differs from at least one auditory prompt associated with the other skins of the plurality of skins. In some embodiments, the auditory prompt set associated with a skin may be stored on the memory unit. In other embodiments, the auditory prompt set associated with the skin may be stored on the skin or on a server. The control unit may also comprise a speech unit and instructing the speaker to output at least one auditory prompt from the active prompt set may comprise transmitting a signal associated with the at least one auditory prompt from the speech unit to the speaker. In some variations, the analyte measurement devices described here may further comprise a display and/or a microphone. In some embodiments, the analyte measurement device may be an integrated meter. In some variations, the system may further comprise a cartridge.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-1B depict a front view, and a perspective bottom view, respectively of a variation of an analyte measurement device as described here. FIG. 1C depicts a perspective view of a cartridge that may be used with an analyte measurement device described here.



FIG. 2A depicts a perspective view of a cartridge. FIG. 2B depicts an exploded view of a sampling arrangement contained in a cartridge.



FIGS. 3A and 3B depict block diagrams of variations of the analyte measurement devices described here.



FIG. 4 depicts a schematic representation of a server system.



FIGS. 5A and 5B depict front views of a variation of the analyte measurement devices described here.



FIGS. 6A and 6B depict front views of a variation of the analyte measurement devices described here.



FIG. 7A depicts a perspective view of a variation of an analyte measurement device described here comprising an additional housing portion. FIG. 7B depicts a back view of a variation of an analyte measurement device comprising a removable housing portion. FIG. 7C depicts a back view of an analyte measurement device with the back cover removed.



FIGS. 8A and 8B depict a front view and perspective view respectively of a variation of the analyte measurement devices described here with a skin. FIGS. 8C and 8D depict top perspective views of a variation of the analyte measurement devices described here without a skin, and with a skin, respectively.





DETAILED DESCRIPTION

Described here are analyte measurement systems and devices, and methods of using the same. Generally, the devices described here comprise an analyte measurement device configured to audibly communicate with a user. In some embodiments, the analyte measurement devices audibly and/or visually communicate with the user by outputting prompts or receiving commands. In some variations, the analyte measurement devices may be configured with an auditory and/or visual output based on one or more removable components of the analyte measurement device. In these variations, the systems may comprise an analyte measurement device and one or more removable components (e.g., a removable portion of a housing, a cartridge, a skin, or the like).


Analyte Measurement Devices


Generally, the analyte measurement devices described here are configured to perform one or more steps of an analyte measurement operation in which the concentration of one or more analytes in a fluid sample is measured. For example, an analyte measurement device may be configured to perform one or more of the following operations: collect a fluid sample from a sampling site, transport the fluid sample to an analysis site, and analyze the fluid sample. When the analyte measurement device is configured to collect a fluid sample from a sampling site, the device may be configured to collect a fluid sample from any suitable sampling site. Examples of suitable sampling sites include, but are not limited to, one or more body sites (e.g., fingers, toes, other skin surfaces, or the like) or one or more artificial containers (e.g., a vial holding a control solution or a body fluid sample). The fluid sample may comprise any suitable fluid, such as, for example, one or more solutions (e.g., a control solution), mixtures, body fluids (e.g., blood, saliva, or the like), combinations thereof and the like. Analysis of a fluid sample may include determining the concentration of one or more analytes in the sample, such as one or more hormones, proteins, enzymes, toxins, drugs, other molecules, or the like. In some variations, the analyte measurement devices described here may be configured to measure the glucose concentration of one or more blood samples or other glucose-containing solutions.


In some variations, an analyte measurement device as described here may be fully integrated, in that the device may contain all of the components necessary for collecting, transporting, and analyzing a fluid sample. For example, the systems described here may comprise one or more of the devices described in U.S. patent application Ser. No. 13/566,886, filed Aug. 3, 2012 and titled “DEVICES AND METHODS FOR BODY FLUID SAMPLING AND ANALYSIS,” U.S. Pat. No. 7,004,928, filed Apr. 23, 2002 and titled “AUTONOMOUS, AMBULATORY ANALYTE MONITOR OR DRUG DELIVERY DEVICE,” and U.S. Pat. No. 8,012,103 and titled “CATALYSTS FOR BODY FLUID SAMPLE EXTRACTION,” the contents of each of which are hereby incorporated by reference in their entirety. It should also be appreciated that the analyte measurement devices described here may be configured to perform only a subset of the collecting, transporting, and analyzing operations associated with analysis of a fluid sample.


For example, the analyte measurement device may comprise a fully integrated meter. The meter may comprise a meter housing and one or more cartridges, which will be described in more detail below. In some variations, the meter may be configured to collect and analyze a plurality of fluid samples. For example, in some variations, a cartridge may comprise one or more cells, some or all of which may contain one or more sampling arrangements for collecting a fluid sample, as described in more detail below. The meter may be further configured to audibly, visually or otherwise provide one or more results from the sample analysis. Some portions of the meter may be reusable, while other portions of the meter may be disposable. For example, in some variations, the meter housing is reusable while the cartridge is disposable. In these variations, new cartridges may be inserted into or otherwise engage with a meter housing to conduct a new series of tests. In other variations, both the meter housing and the cartridge may be disposable.



FIGS. 1A-1C show an illustrative variation of an exemplary integrated meter (100). Specifically, FIGS. 1A and 1B show a front view and a bottom perspective view, respectively, of a meter housing (118), while FIG. 1C shows a perspective view of the cartridge (102). While shown in FIG. 1C as being stored in a sealed or sealable pouch (116), the cartridge (102) may be stored in any suitable container, and may be removed prior to use. As shown in FIGS. 1A and 1B, the meter housing (118) may comprise a door (104) with a cartridge-engagement projection (105), a cartridge-receiving chamber (106) or cavity, a cartridge ejection button (113), a display (108), buttons (110), a port (112), and a tower (114). The meter need not include each of these features, and it should be appreciated that the meter may comprise any combination of these features. The meter (100) may further comprise one or more imaging systems (not shown), and internal mechanisms or components (e.g., memory, circuitry, actuators, batteries, vacuum pumps, sensors, combinations thereof, etc.) for operating the meter and/or facilitating a testing procedure.


A cover or door (104) may be opened to reveal a cartridge-receiving chamber (106), as shown in FIG. 1B. A cartridge (102) may be placed inside of cartridge-receiving chamber (106), and the door (104) may be closed to temporarily enclose the cartridge (102) within the meter housing (118). When placed inside of the meter housing, one or more portions of the cartridge (102) may engage one or more components of the meter housing (118). In some variations, the meter housing (118) may comprise one or more features that may facilitate self-alignment of the cartridge (102) as it is placed in the cartridge-receiving chamber (106). For example, in some variations the cartridge (102) may comprise a recess (not shown). When the cartridge (102) is placed inside of the cartridge-receiving chamber (106), a portion of the tower (114) may fit within or otherwise engage the recess of the cartridge (102). This engagement may help to hold the cartridge (102) in place relative to meter housing (118). Conversely, in some variations, the cartridge (102) may comprise one or more projections (not shown) that may engage one or more recesses (not shown) in the cartridge-receiving chamber (106) or other portion of the meter housing (118). Additionally or alternatively, one or more magnets may hold the cartridge in place relative to the meter housing. A cartridge need not be placed inside of a meter housing (e.g., via a cartridge-receiving chamber) to engage the meter housing. For example, in some variations, a cartridge may attach to or otherwise engage one or more external surfaces of a meter housing.


Any suitable cartridge may be used with the meters. For example, in some variations, the meter may comprise one or more of the cartridges described in U.S. patent application Ser. No. 11/529,614, titled “MULTI-SITE BODY FLUID SAMPLING AND ANALYSIS CARTRIDGE,” and U.S. Pat. No. 8,231,832, titled “ANALYTE CONCENTRATION DETECTION DEVICES AND METHODS,” the contents of each of which is hereby incorporated by reference in its entirety. A suitable variation of a cartridge that may be used with the meter described above is illustrated in FIG. 2A. As shown there, the cartridge (200) may house or otherwise hold one or more sampling arrangements (202). These sampling arrangements (202) may comprise one or more components for collecting, transporting, and/or reacting with a fluid sample. For example, in some variations, the sampling arrangement may comprise a penetration member for piecing, penetrating or otherwise puncturing a sampling site during a testing procedure. In variations where the cartridge (200) comprises a plurality of sampling arrangements (202), each sampling arrangement (202) may be utilized to conduct a separate test on a different fluid sample. The sampling arrangement may further comprise a hub or other structure for moving the penetration member relative to the cartridge. Additionally, the sampling arrangement (202) may comprise a quantification member (not shown), which may react with the fluid sample to produce a measurable response (e.g., an electrochemical or photometric response) that may be indicative of one or more properties of the fluid sample. In variations where the cartridge (200) is configured to be disposable, new cartridges may be swapped in to provide unused (e.g., unfired) sampling arrangements. Any reactions that occur between sampling arrangement and the fluid sample may be quantified or measured by one or more portions of the cartridge or the meter housing (e.g., an imaging system). In some variations, one or more portions of the cartridge may be reusable. For example, a cartridge containing one or more unused sampling arrangements may be loaded into the cartridge to allow the meter to conduct additional testing procedures. While the meter (100) is discussed above as having a cartridge, the meter need not.



FIG. 2B depicts an exploded view of a sampling arrangement (202). Shown there are a hub (204), a skin penetration member (206), a quantification member (208) (e.g., a pad), a cap (210), and a spring (212). The hub (204) may comprise a latch (214), pivot bars (216), and a micropatterned surface (218). In this variation, the hub (204) may hold the skin penetration member (206) such that an interior bore (220) of the skin penetration member (206) is in fluid communication with the micropatterned surface (218). The quantification member (208) may be placed on the micropatterned surface (218) and a cap (210) may be placed at least partially over the quantification member (208) to hold the quantification member (208) in place against the micropatterned surface (218). The cap (210) may comprise an aperture (222) through which the quantification member (208) may be viewed by an imaging system (e.g., light source and detector) to determine the concentration of an analyte in a sample. While spring (212) is depicted as a torsional spring, any mechanism capable of moving the skin penetration member may be utilized (e.g., linear spring, leaf spring, conical spring, mechanically-driven arm, sliding actuator etc.).


The meter housing (118) may be configured to house a speaker and/or a microphone (not shown) and a control unit (not shown), although it should be appreciated that the speaker, microphone, and/or control unit may in some instances be partially housed in the housing (118), may be externally attached to the housing (118), or may be part of a separate device (i.e., headphones, cellular phone, computer, tablet, etc.) that communicates with the meter either wirelessly or through a wired connection. As depicted in FIG. 1A, the meter housing (118) may additionally comprise a display (108) (e.g., for visually providing information to a user), buttons (110) (e.g., for powering on/off the device, inputting information into the device, etc.) and a port (112) (e.g., through which a fluid sample may be collected), such as those described in U.S. patent application Ser. No. 13/566,886, which was previously incorporated by reference in its entirety. Additionally or alternatively, the meter (100) may in some instances further comprise one or more imaging systems (not shown), and internal mechanisms or components (e.g., memory, circuitry, actuators, batteries, vacuum pumps, sensors, combinations thereof, etc.) for operating the meter (100) and/or facilitating testing of a fluid sample The analyte measurement devices described here need not include each of these features, and variations of these devices may comprise any combination of these features.


As mentioned above, the analyte measurement devices described here are generally configured to provide some form of feedback (auditory, visual, tactile, etc.) to a user. Generally, the analyte measurement devices described here may comprise a control unit comprising a memory unit (which can include one or more computer-readable storage mediums), one or more processors (CPU's), and a speech unit. The one or more processors may execute various software programs and/or sets of instructions stored in the memory unit to perform various functions for the device and to process data. In some examples, the memory unit, processor and speech unit may be implemented on a single chip. In other examples, they can be implemented on separate chips. Depending on the desired functionality of the device, the device may further comprise any number of components, including but not limited to, circuitry of any kind (e.g., RF circuitry, audio circuitry, display circuitry, lighting circuitry, integrated circuits, etc.), a speaker, a microphone, a tactile output generator (e.g., a vibrational element), a display (including a touch-sensitive display system), one or more external ports, etc. The device may include all of the above listed components, or any sub combination of the components. Additionally, the various components described may be implemented across two or more devices (e.g., an analyte measurement device and a cellular phone), of which one or more may include a home computer, or a remote server accessed by a local area network or by the internet. In an example where two or more devices are used, the devices can communicate with each other to facilitate operation of the devices. The communication may or may not be encrypted.


The analyte measurement devices may also be configured to receive, compile, store, and access data. In some variations, the analyte measurement device may be configured to access and/or receive data from different sources. The analyte measurement device may be configured to receive data directly entered by a user and/or it may be configured to receive data from separate devices (e.g. a cellular phone, tablet, computer, etc.) and/or from a storage medium (flash drive, memory card, etc.). The analyte measurement device may receive the data through a network connection, as discussed in more detail below, or through a physical connection with the device or storage medium (e.g. through USB or any other type of port). The analyte measurement device may compile the data using a processor and may store the data on a memory unit within the access device, or it may transmit the data to an external server for storage. Furthermore, the analyte measurement device may later access the stored data using the processor.


The analyte measurement device may be configured to receive various types of data. For example, the analyte measurement device may be configured to receive a user's personal data (e.g., gender, weight, birthday, age, height, diagnosis date, anniversary date using the device, etc.), a user's testing history (e.g., number of tests completed, time each test was completed, date each test was completed, pre or post prandial test markings, how many tests a user has completed consecutively, etc.), a user's results history (e.g., glucose level at time test was taken), a user's diet information (e.g., what a user had to eat each day, number of alcoholic beverages, amount of carbohydrates consumed, etc.), a user's exercise information (e.g., if a user exercised, when the user exercised, duration of exercise, what type of exercise the user completed (e.g. biking, swimming, running, etc.), exertion level of the exercise (e.g., low, medium, high), a user's heart rate during exercise, etc.), general health information of other similarly situated patients (e.g., typical test results for a similar user at a similar time of day, average of test results for a similar user after exercise, etc.), or any other information that may be relevant to a user's treatment. In some variations, the analyte measurement device may be configured to create, receive, and/or store user profiles. A user profile may contain any of the user specific information previously described. Additionally, the analyte measurement device may be configured to receive general information useful in determining when testing occurs (e.g., time of day, date, location) as is described in more detail in U.S. patent application Ser. No. 12/457,332, titled “MEDICAL DIAGNOSTIC DEVICES AND METHODS,” the content of which is hereby incorporated by reference in its entirety. While the above mentioned information may be received by the analyte measurement device, in some embodiments the analyte measurement device may be configured to calculate any of the above data from information it has received using software stored on the device itself, or externally.


In some embodiments, the analyte measurement device may be configured to identify patterns in user behavior, use the identified patterns to predict future user behavior, and provide prompts to the user relating to the identified patterns, as is described in more detail in U.S. patent application Ser. No. 12/457,332, titled “MEDICAL DIAGNOSTIC DEVICES AND METHODS,” which was previously incorporated by reference in its entirety. In some instances, the analyte measurement device may use the patterns to help warn about, or prevent the occurrence of one or more glucose events. A glucose event may occur any time a user's glucose is above or below an expected level or is outside a specified range. In some embodiments, a glucose event may be a hypoglycemic event or a hyperglycemic event. In some variations, the analyte measurement device may be configured to compare the user's personal data, testing history, diet information, exercise information, or any other relevant information, to a user's historical data (e.g. prior test data, user's historical trends, etc.), data preloaded onto the analyte measurement device that has been compiled from external sources (e.g. medical studies), or data received from a separate device (e.g., historical data or data compiled from external sources), as is described in more detail below. In some instances, the warning or notification may include instructions to perform a test, seek medical attention, and/or to eat or drink something.


The analyte measurement device may be configured to calculate the likelihood of a glucose event based on data it has received and may provide an alert or prompt to a user based on its calculation. In some variations, the method of alerting a user of a glucose event may comprise receiving user information, identifying the user information as a stimulus for a glucose event (e.g., exercise, alcohol consumption, sugar consumption, heavy meals, etc.), calculating a likelihood of occurrence of the glucose event, determining when the glucose event will occur, and alerting or prompting the user in advance of the glucose event based on the determination of when the glucose event will occur. The reporting of a risk, if any, may be based upon whether the risk calculation meets or exceeds a certain threshold, or certain criteria.


For example, some users may experience a higher risk of a glucose event after intense exercise (e.g., high intensity for 60 minutes, moderate intensity for 90 minutes, low intensity for 120 minutes) or after consuming a certain number or amount of alcoholic beverages (e.g. 5 glasses of wine, 4.5 ounces of vodka, etc.). The user may input information about his exercise regimen or alcohol consumption into the analyte measurement device or a separate device communicating with the analyte measurement device. The analyte measurement device may identify the information as a stimulus for a glucose event based on data preloaded onto the analyte measurement device, data received from a separate device, and/or a user's historical data, and may mark the information as a stimulus. The analyte measurement device may compare the user's information to the preloaded, received, and/or historical data to calculate a likelihood of occurrence of the glucose event. If there is a high probability that a glucose event may occur, the analyte measurement device may use the preloaded, received, and/or historical data to determine when the event is likely to occur (e.g., 12 hours after exercising, 4 hours after consuming alcohol, etc.), and may alert or prompt the user at an appropriate time (e.g., 11 hours after exercising, 3 hours and 45 minutes after consuming alcohol, etc.), as is described in more detail below.


In some embodiments, calculating the likelihood of the occurrence of a glucose event may comprise comparing the user's information with the user's historical information (e.g. prior test result, historical average, historical trend, predictive value, etc.) assigning a probability of a glucose event occurring based on the comparison, determining if the probability is larger than a threshold value, and if so, determining that alerting or prompting a user is necessary. In other embodiments, calculating the likelihood of the occurrence of a glucose event may comprise comparing the user's information with the health information of other patients, for example, similarly situated patients (e.g., patients of similar age, weight, patterns, etc.). In yet other embodiments, calculating the likelihood of the occurrence of a glucose event may comprise comparing the user's information with both the user's historical information and the health information of similarly situated patients, assigning a probability to each comparison, and averaging the probabilities. While a simple average is described, a more complex weighting scheme may be utilized. For example, in some embodiments, the comparison of the user's information with the user's historical information may be weighted more heavily than the comparison of the user's information with the health information of similarly situated patients. In still other variations, calculating the likelihood of the occurrence of a glucose event may comprise comparing many different factors (e.g., duration of exercise, intensity of exercise, last meal, and age) with the same factors in multiple data sets (e.g., historical data, similarly situated patient data, etc.) and assigning each factor a different weight to determine a final probability.


In some examples, determining when the glucose event will occur may also comprise comparing the user's information with the user's historical information or the health information of similarly situated patients. This comparison may provide information about how much time may elapse between the stimulus and the glucose event (i.e. a response time). The response times may also be averaged or assigned weights.



FIGS. 3A and 3B show block diagrams of variations of another analyte measurement device (300). As shown in FIG. 3A, the analyte measurement device (300) may comprise a speaker (302) configured to produce a sound output, and a control unit (304) configured to control the sound output of the speaker (302). The control unit (304) may include electronics capable of outputting audio signals to the speaker (302). For example, in the variations shown in FIGS. 3A and 3B, the control unit (304) may comprise a processor (306), a speech unit (308), and a memory unit (310). The memory unit (310) can include high-speed random access memory and non-volatile memory, such as one or more magnetic disk storage devices, flash memory devices, or other non-volatile solid-state memory devices. In the variation depicted in FIG. 3A, the memory unit (310) may be configured to store data relating to a plurality of sound outputs for the speaker (302), the processor (306) may be configured to select a specific sound output from the plurality of sound outputs, and the speech unit (308) may be configured to convert the data relating to the sound output into a signal that may be transmitted to the speaker (302), or a wireless audio transmitter, e.g. IR, Bluetooth, wireless USB protocol, WiFi IEEE 802.11x protocols, 2.4 GHz or 5 GHz transmissions. The speaker (302) may then convert the signal to human-audible sound waves. The data relating to the sound output may comprise any audio file, for example, sample sound files, a library of sounds, recorded data files, sound files that may be used together to form composite speech, or any other type of audible indicia file. In some variations, the analyte measurement device (300) may include a headset jack instead of, or in addition to, a speaker (302). The headset jack may provide an interface between the speech unit (308) and removable audio output devices, such as output-only headphones, an external speaker, or a headset with both an output (e.g. a headphone for one or both ears) and an input (e.g., a microphone.)


In some variations, the analyte measurement device (300) may also comprise a vibrational element (314), for example, a vibrating motor or the like, such that the analyte measurement device may provide tactile feedback to a user. The tactile feedback may be provided to the user through the housing (118), the port (112), or any other component of the device capable of transmitting vibration. In this variation, the memory unit (310) may be configured to store data relating to a plurality of vibrational patterns, and the processor (306) may be configured to select a specific pattern from the plurality of vibrational patterns and communicate with an actuator configured to activate and deactivate the vibrational element.


In some variations, the analyte measurement device (300) may also be configured to produce a visual output to communicate information to a user. As shown in FIG. 3A, the analyte measurement device (300) may comprise a display (318) configured to produce a visual output, and a control unit (304) configured to control the visual output of the display (318). The display (318) may use LCD (liquid crystal display) technology, LPD (light emitting polymer display) technology, and/or LED (light emitting diode) or OLED (organic LED) technology, although other display technologies can be used in other examples. As mentioned above, the display (318) may also use touch sensing technology, including but not limited to, capacitive, resistive, infrared and surface acoustic wave technologies, other proximity sensor arrays, or other elements for determining one or more points of contact with the display (318), such that the display (318) may also act as a touchscreen. The control unit (304) may include electronics capable of outputting visual signals to the display (318). In the variation depicted in FIGS. 3A and 3B, the memory unit (310) may be configured to store data relating to a plurality of visual outputs for the display (318) and the processor (306) may be configured to select a specific visual output from the plurality of visual outputs and communicate with the display (318) such that the selected specific visual output appears on the display (318). While the display (318) is depicted in FIGS. 3A and 3B as an integrated display, the analyte measurement device (300) may not comprise a display (318) and a separate interface may be used to display information (e.g., a cellular phone, computer, tablet, etc.).


In some embodiments, the analyte measurement device (300) may also be configured to detect and respond to audible commands. As depicted in FIG. 3B, the analyte measurement device (300) may comprise a microphone (312) configured to detect sound, and a control unit (304) configured to interpret and control how the detected sound is utilized by the analyte measurement device (300). The control unit (304) may include electronics capable of detecting sound and converting it into instructions for the device. For example, the control unit (304) may comprise a processor (306), a speech unit (308), and a memory unit (310). The microphone (312) may be configured to detect an audible command and convert it into a data signal, the speech unit (308) may be configured to convert the data signal into instructional data for the analyte measurement device, the memory unit (312) may be configured to store instructional data relating to a plurality of instructions, and the processor (306) may be configured to select a specific instruction from a plurality of instructions stored on the memory unit (312) and implement it. In some embodiments, the analyte measurement device (300) may include a headset jack instead of, or in addition to, a microphone (310). The headset jack may provide an interface between the speech unit (308) and removable audio input devices, such as an external microphone or a headset with both an output (e.g. a headphone for one or both ears) and an input (e.g., a microphone).


In some variations, the analyte measurement device may communicate with and provide auditory, visual, or other information to a separate user device. For example, FIG. 3B depicts a variation of an analyte measurement device (300) comprising RF (radio frequency) circuitry (316). The RF circuitry (316) may receive and send RF signals. The RF circuitry (316) may convert electrical signals to/from electromagnetic signals and communicate with communications networks and other communications devices via the electromagnetic signals. The RF circuitry (316) may comprise well-known circuitry for performing these functions, including but not limited to an antenna system, an RF transceiver, one or more amplifiers, a tuner, one or more oscillators, a digital signal processor, a CODEC chipset, a subscriber identity module (SIM) card, memory, and so forth. The RF circuitry (316) may communicate with networks, such as the network (406) illustrated in the exemplary communication system (400) depicted in FIG. 4.



FIG. 4 depicts an exemplary system (400) for sending and receiving auditory, visual, or other information between user devices (402, 404). The first user device (402) may be an analyte measurement device, such as the analyte measurement device (300) depicted in FIGS. 3A-3B, and the second user device (404) may include any of a variety of devices, such as a cellular telephone (e.g., smartphone), tablet computer, laptop computer, desktop computer, portable media player, wearable digital device (e.g., digital glasses, wristband, wristwatch, brooch, armbands, etc.), television, set top box (e.g., cable box, video player, video streaming device, etc.), gaming system, or the like. While two user devices (402, 404) are depicted, any number of user devices (402, 404) could be included in the system (400).


The user devices (402, 404) may transmit data (e.g. user data, test data, audible prompts, visual prompts, etc.) to the server system (408) through the network (406). The network (406) may include any of a variety of networks, such as a cellular telephone network, WiFi network, wide area network, local area network, the Internet, or the like. The user devices (402, 404) may communicate with the network (406) by wireless communication. The wireless communication may use any of plurality of communication standards, protocols and technologies, including but not limited to, Global System for Mobile Communications (GSM), Enhanced Data GSM Environment (EDGE), high-speed downlink packet access (HSDPA), high-speed uplink packet access (HSUPA), Evolution, Data-Only (EV-DO), HSPA, HSPA+, Dual-Cell HSPA (DC-HSPDA), long term evolution (LTE), near field communication (NFC), wideband code division multiple access (W-CDMA), code division multiple access (CDMA), time division multiple access (TDMA), Bluetooth, Wireless Fidelity (WiFi) (e.g., IEEE 802.11a, IEEE 802.11b, IEEE 802.11g and/or IEEE 802.11n), voice over Internet Protocol (VoIP), Wi-MAX, a protocol for e-mail (e.g., Internet message access protocol (IMAP) and/or post office protocol (POP)), instant messaging (e.g., extensible messaging and presence protocol (XMPP), Session Initiation Protocol for Instant Messaging and Presence Leveraging Extensions (SIMPLE), Instant Messaging and Presence Service (IMPS)), and/or Short Message Service (SMS), or any other suitable communication protocol. In some variations, the user devices (402, 404) may directly communicate with each other without transmitting data through the network (406) (e.g., through NFC, Bluetooth, WiFi, and the like.)


The server system (408) may include a server, storage devices (including cloud based storage), databases, and the like and can be used in conjunction with the user devices (402, 404) to transmit data. For example, in variations in which one of the user devices (402) is one of the analyte measurement devices (300) depicted in FIGS. 3A-3B, the user device (402) may receive information from a user, optionally process the information, transmit some or all of the entered and/or processed information to the server system (408), receive information from the server system (408), and output an auditory, visual, or tactile prompt from the device (402). The user device (402) may optionally transmit information to the second user device (404) which may also output an auditory, visual, or tactile prompt. In some embodiments, both user devices (402, 404) may receive information from the server system (408), and output an auditory, visual, or tactile prompt. In some variations, the server system (408) may process and/or store the information. In some instances, the user device (402) may receive and process information without the server system (408) and/or the network (406) and may transmit information about an auditory, visual, or tactile prompt to the server system (408) to transmit to the second user device (404), which may receive the information and output an auditory, visual, or tactile prompt. Any type of information can be transmitted and the server system (408) and the user devices (402, 404) may transmit information through the network (406) as many times as necessary.


For the purposes of this application, a specific output and any data or signal corresponding thereto will be referred to as a “prompt.” Likewise, for the purposes of this application, a specific user input and any data or signal corresponding thereto will be referred to as a “command.” For example, a specific sound output and any data or audio signals corresponding thereto will be referred to as an “auditory prompt,” a specific visual output and any data corresponding thereto will be referred to as a “visual prompt,” and a specific auditory input and any data or audio signals corresponding thereto will be referred to as an “auditory command.”


An auditory prompt may include speech, music, sounds, combinations thereof, and the like, such as will be described in more detail below. In some instances, the analyte measurement device may be configured to produce auditory prompts that can audibly guide users through one or more operations of the device. For example, in variations where the analyte measurement device is an integrated device, the analyte measurement device may be configured to audibly guide a user through an entire sampling process to obtain and analyze a fluid sample to determine a concentration or other measurement of a target analyte. As an example, some variations of the analyte measurement devices described here may audibly inform a user that the device has been woken from a sleep/powered off state, that the device is ready to acquire a sample, that the device is acquiring a sample, that a sample has been acquired (or in some instances, that an additional sample needs to be applied to the device), and that the sample is being analyzed. The analyte measurement device may then present the results of the analysis (e.g., a concentration of blood glucose in the sample).


A visual prompt may include text, graphics, symbols, or combinations thereof, and the like, such as will be described in more detail below. Similarly to the audible prompts discussed above, in some instances the analyte measurement device may be configured to produce visual prompts that can visually guide a user through one or more operations of the device or otherwise convey information about a user's testing history or results.


An auditory command may include speech or sounds, or a combination thereof, and the like, such as will be described in more detail below. A user may use auditory commands to instruct the analyte measurement device to perform specified tasks.


Prompts


Typically, analyte monitors (such as glucose monitors) visually communicate information to a user (e.g., via a display). For example, the analyte monitors may visually display a concentration of an analyte in a sample (e.g., a glucose reading), or may visually display prompts that instruct the user to take one or more actions associated with an analyte measurement operation (e.g., insert a test strip or other test media, apply a sample to the test media, wait for analysis). This type of visual communication normally consists of simple text appearing on the display. The analyte measurement devices described here may be configured to provide information visually and/or audibly to a user (e.g., via the display (318) or the speaker (302) of the device (300) shown in FIG. 3A) in a customized manner. Generally, presenting information audibly may promote or otherwise facilitate the use of the analyte measurement devices by users with vision problems, as auditory prompts may allow a vision-impaired user to perform actions with the device (e.g., to complete the analysis of an analyte) without needing assistance from another user. Additionally, presenting information (visually, audibly, or otherwise) in a customized manner, as will be discussed in more detail below, may provide a more enjoyable user experience and may therefore increase user compliance (e.g., whether the user tests as directed).


Generally, the analyte measurement devices described here may be configured to output one or more prompts during use of the device. Typically, a prompt may be outputted in response to an action taken by a user or on a scheduled basis. For example, in some variations an analyte measurement device may provide a prompt when the device is powered on or otherwise awoken from a low-power sleep state. The prompt may provide a greeting, may inform a user of the current time, or the like. When a user initiates an analyte measurement operation (e.g., a testing sequence), the analyte measurement device may output one or more prompts that may guide the user through one or more steps of the analyte measurement operation. For example, a prompt may instruct a user to insert a test strip into the device, to place a sampling site such as a finger on a test port, to apply or reapply a sample to a test port, combinations thereof and the like. Prompts may also instruct a user as to the status of the analyte measurement operation (e.g., a prompt may inform a user that the device is obtaining a sample or is analyzing the sample) or the results of the analyte measurement operation (e.g., the concentration of a given analyte in the sample). The analyte measurement devices may also be configured to output multiple prompts at the same time. For example, the analyte measurement devices may be configured to output both an auditory prompt and a visual prompt in response to a single action taken by a user or on a scheduled basis.


Turning to FIGS. 5A-5B, in some variations, one or more prompts (502) may be dependent on a specific time, date, measurement, or use of the device (500). The analyte measurement device (500) may be configured to receive, compile, store, and/or access data, as is described above in more detail. In some variations, the analyte measurement device (500) may incorporate this data in the given prompts (502). FIG. 5A depicts an example of a variation of the devices (500) described here outputting a prompt (502) that may be dependent on the time of day. As seen there, the device (500) may be configured to recognize the time of day (e.g., morning) and to output a prompt or prompts (502) that correlate with it (e.g., a rising sun, “good morning”). The device (500) may be configured to recognize any time of day (e.g., lunch time, evening, night, hours during which the user is at work, hours at which the user is sleeping, etc.) and may output prompts that correlate with the recognized time. In other variations, a device may output a prompt (502) on certain days of the week (e.g., “Happy Friday,” graphic of calendar with day of week or date), or certain days of the year (e.g., “Happy birthday!”, graphic of birthday cake, display age with balloons). In some instances, a prompt (502) may be dependent on the user's testing frequency. For example, as described above in more detail, the analyte measurement device (500) may be configured to record the number of analyte measurement operations performed by a user during a given span of time and the corresponding results, and create a data set that can later be referenced by the device. The analyte measurement device (500) may be configured to output a prompt (502) that provides the user with information about his/her testing history and results. For example, the analyte measurement device (500) may output a prompt (502) that informs a user of his/her compliance with an expected testing regimen (or lack thereof), that encourages the user to better comply with the regimen, that informs a user of how many tests he/she has completed (consecutively, this week, total, etc.), and the like.


For example, if a user is complying with the expected testing regimen (e.g., consecutively or consistently testing at prescribed times), the prompt (502) may praise the user (e.g., “You're doing great! Keep it up!”, “Way to go! You've tested 4 days in a row!”, a graphic of a medal with a numerical indication of compliance, graphic of a check mark, etc.). Conversely, if the user is not complying with the expected testing regiment, the prompt (502) may inform the user of this (“You haven't been testing 2 times a day as prescribed by Dr. Simmons. Maybe you should test more often”, graphic of a sick patient, graphic of an “X”, etc.).


Similarly, the prompts (502) may depend on the results of one or more analyte measurement operations, as is depicted in FIG. 5B. For example, if a concentration or the concentrations measured during the analyte measurement operations is consistently within a prescribed range (e.g., for three consecutive tests, two out of three consecutive tests, or the like), the prompt (502) may praise the user (e.g., “Your results look great”, graphic of a smiley face, etc.). If a concentration or the concentrations measured is consistently outside of a prescribed range (e.g., for three consecutive tests, two out of three consecutive tests, or the like), the prompt (502) may encourage the user to test more frequently, to consult a physician or to change the user's diet (e.g., “You may want to test more often,” “You may want to speak to Dr. Simmons about your test regimen”, a graphic of a doctor on the telephone, a graphic of a piece of candy, etc.). If a user consistently tests at certain times throughout the day and the user fails to test at a time previously identified as a regular testing time, the prompt (502) may remind the user to test (“Did you forget to test today?”, graphic of an analyte measurement device flashing on the display with a question mark, etc.). If the time a user tests is consistently outside of a prescribed or historically calculated range, the prompt (502) may remind the user to test before the prescribed or historically calculated range passes (e.g., “Don't forget to test at 2 pm”, graphic of a set clock and an exclamation mark, etc.).


Moreover, one or more of the prompts (502) may depend on the results of a determination of when a glucose event may occur, as is discussed in detail above. For example, a prompt (502) may inform a user of the likelihood of a glucose event occurring (e.g., “80%”, graphic of a partially filled thermometer with a scale from 1-100%, etc.). In some variations, the prompt (502) may inform a user that a glucose event may occur imminently (e.g., “You may begin to feel dizzy”, a graphic of a hospital, etc.) and/or that immediate action is required (e.g., “Please test immediately”, “Please eat carbohydrates”, a graphic of a user testing, a graphic of a suggested food, etc.). In some variations, the prompt (502) may inform a user that a potentially glucose event may occur in the future (e.g., “You may have low blood sugar in 2 hours”, “graphic of clock with an exclamation point, etc.) and/or suggest an action the user may wish to take in the future (e.g., “Please test again in 1 hour”, “Please eat a snack in 30 minutes”, a graphic of a clock with an analyte testing device, etc.).


While the prompts (502) are described as being output to/on the analyte measurement device (500) itself, in some variations, the prompts may be output on a separate device (504) in communication with the analyte measurement device, as is described above in detail with respect to FIG. 4. For example, a user may interact with an analyte measurement device (500) in some capacity (e.g., turn the device on, turn the device off, begin a test sequence, finish a test sequence, etc.) and a prompt (502) may be output on one or more separate devices (504) (e.g., a cellular phone, computer, tablet, etc.). In some variations, a prompt (502) may be output on a separate device (504) that is used or can be accessed by another person (e.g., a computer at the user's doctor's office, a cellular phone of a relative or caretaker, etc.). In other variations, a prompt (502) may be output on a separate device (504) that is used or can be accessed by the user (e.g., the user's cellular phone, the user's computer, the user's headphones (for audible prompts) etc.). In some embodiments, a prompt (502) may be output on both the analyte measurement device (500) and a separate device (504), as is depicted in FIG. 5A. Additionally, in some embodiments, the analyte measurement device (500) may be in communication with applications that are running on or are stored on a separate device (504), and may be able to receive and/or send data to/from the applications on the separate device (504). For example, in an embodiment in which a prompt (502) may be output to inform the user that a glucose event may occur now or in the future, the analyte measurement device (500) may communicate with an alarm clock application running or stored on a separate device (504) and may program the alarm clock to sound at a later time to output the prompt (502).


Commands


Generally, the analyte measurement devices described here may be configured to receive one or more commands during use of the device. Typically, a command may be given by a user and received by the device. For example, in some variations, a user may give a command after the device is powered on or otherwise awoken from a low-power sleep state. The command may provide instructions to the device or may otherwise communicate an action the user desires the device complete. For example, a user may provide an audible command (e.g., “Wake-up”, “Turn-Off”, “Begin Test”, etc.), the device may receive the audible command, and the device may respond by completing the user's desired instruction (e.g., waking-up from low-power sleep state, turning-off, beginning a test sequence, etc.). In some variations, the user may provide an audible command requesting information about the user and/or his/her current or historical test results (e.g., “What is my blood sugar?”, “What was my blood sugar on Tuesday?”), the device may receive the command, access the requested information, and respond with a prompt comprising the information requested by the user. In some embodiments, the requested information may comprise information about the status of the testing sequence or any other information that may be of interest to a user.


Auditory Prompts


As mentioned above, the analyte measurement device may output an auditory prompt in response to an action taken by the user (e.g. starting a test sequence) or on a scheduled basis (e.g. a reminder to test at a certain time every day). Auditory prompts may also be used to read on-screen menus and options, to guide a user through setting or changing one or more options (e.g., setting a device clock, setting an alarm or reminder, controlling a vacuum pump or display backlight). Table 1 below provides a plurality of examples of auditory prompts that may be outputted by the analyte measurement devices described here.











TABLE 1





Auditory prompt
Possible Triggering Action
Examples







Auditory prompt configured to
Device is powered on/awoken
“Welcome to POGO ®”


alert user that device is in an
from low-power sleep state
“Good morning, Jane”


operational state and/or provide

“The time is 3:21 pm”


a greeting

“The device is ready for use”


Auditory prompt to instruct
User activates a analyte
“Please apply your finger to the


user to position a sampling site
measurement operation
test port”


(e.g., a finger) relative to a


sample acquisition portion of


the device (e.g., a test port)


Auditory prompt to indicate
The analyte measurement
“Prepare for sampling: 3. 2. 1.”


that sampling or lancing will
device determines that the


occur (e.g., the device will
sampling site is positioned


penetrate the skin and/or
relative to a sample acquisition


extract a sample)
portion


Auditory prompt to instruct
The analyte measurement
“POGO ® is obtaining a


user to maintain sampling site
device has pierced or lanced the
sample, please hold your finger


position and/or provide status
sampling site
on the test port.”


of sampling


Auditory prompt to alert a user
The analyte measurement
“Sample Acquired.”


that a usable sample has been
device determines that a sample


acquired.
has been acquired


Auditory prompt to alert a user
The analyte measurement
“Please apply additional


to apply additional sample to
device determines that a
sample.”


the device (e.g., if the device
sufficient sample size has not


determines that an insufficient
yet been acquired


volume of fluid has been


captured by the device)


Auditory prompt to alert a user
The analyte measurement
“Your blood glucose is 126


that a result has been obtained
device has completed an
mg/mmol.”


and/or measured values
analyte measurement operation










Visual Prompts


Also as mentioned above, the analyte measurement device may output a visual prompt in response to an action taken by the user (e.g. starting a test sequence) or on a scheduled basis (e.g. a reminder to test at a certain time every day). Visual prompts may also be used to guide a user through a test sequence (as is described above in Table 1 with respect to auditory prompts). Visual prompts that guide a user through a test sequence may comprise any visual representation of the steps of the test sequence. For example, simple text may appear on a display explaining what the user should do or a graphical representation of the steps may appear (e.g., a graphic of a finger applied to the test port when a user should apply his/her finger to the test port).


Other types of visual prompts are also contemplated. In some embodiments a light source (e.g., LED) may illuminate a component of the device. For example, a component (the display, a bezel of the display, the test port, the buttons, etc.) may flash or change colors. In some embodiments, the color the component is illuminated may vary based on a user's testing history. For example, if a user has not missed any tests in his/her expected testing regimen, the component may illuminate green. If a user has missed between 0 tests and a selected set-point (e.g. 3 tests, 4 tests, etc.), the component may illuminate yellow. If a user has missed more than a selected set-point of tests, the component may illuminate red. Illumination of the component may be tied to any of a number of variables (e.g., missed tests as described above, time since last test, etc.), and any appropriate set-point (e.g., 3 tests, 3 days since last test, etc.). The set-point may be pre-programmed into the device, input by the user, input by a doctor, or received by the device from an external source. The component may also begin to flash or pulse based on a user's testing history or it may both be illuminated a specified color and flash or pulse.


In some embodiments, visual prompts may be utilized to convey data about a user's testing patterns, trends, and/or results. For example, in some instances, a visual prompt may comprise a graphic that may move or otherwise change positions based on a specified variable (e.g., time, testing frequency, testing consistency, amount of sample received, status of analyte measuring operation, etc.). For example, a graphic may be displaced along the x-axis, the y-axis, or both the x and y axes consecutively or concurrently to convey a change in a specified variable. In some embodiments, a graphic may rotate to indicate a change in a specified variable, or its size or depicted volume may increase or decrease. In other embodiments, a graphic's movement may comprise a combination of displacement, rotation, and volumetric changes.


In some variations, the graphic may change based on the cumulative results of many tests (e.g., number of tests completed in a specific time frame, number of tests with results within a desired range, number of tests completed consecutively, number of days with completed tests within desired range, etc.). For example, each time a user finishes a test, the graphic may be modified to reflect the cumulative result of all of the completed tests. In some instances, the graphic may be modified such that it moves from a first pre-test position to a second post-test position. The movement of the graphic from the first pre-test position to the second post-test position may convey information to the user about the user's testing patterns or results. For example, FIG. 6A is an illustrative example of an analyte measurement device (600) outputting such a visual prompt (602). The visual prompt (602) comprises a mountain (608) with a hiker depicted in a first position (604) and a second position (606). In this example, the mountain (608) may be a graphical representation of the number of tests a user must complete during a set time frame (e.g. 1 day, 2 weeks, etc.) to be fully compliant with the user's regimen. The hiker in the first position (604) may graphically indicate how many tests the user has completed thus far during the set time frame and may appear before a user begins a test sequence. After the user completes the test sequence, the hiker in the second position (606) may appear to indicate to the user that he/she is closer to completing all of the tests necessary to be compliant during the set time frame. In some embodiments, the hiker's displacement from the first position to the second position may appear on the screen such that the hiker appears to be moving. Additionally, it should be appreciated that while the hiker is moving in both the x-axis and the y-axis, the graphics may be configured to move in any direction or to rotate. The graphics may also be configured to move along a rotational path. In some embodiments, the graphic may only move horizontally and vertically and may not rotate, while in other embodiments the graphics may rotate and move in any direction (e.g. along a linear path, rotational path, a zig-zag path, etc.).


In some instances, the graphic may change based on data collected during a single test (e.g., time since test sequence began, number of steps of test sequence completed/remaining, amount of sample collected, etc.). For example, the device may output an active visual prompt as the graphic may change in real-time while the analyte measurement device is completing an analyte measurement operation. As an example, the active visual prompt may comprise a cat drinking water from a bowl and expanding in volume while the device collects a sample from a user. The cat's volume may be indicative of the amount of sample the device has collected and the cat may finish drinking water and move away from the bowl when the device collects a sufficient sample volume. Another example of an active visual prompt (614) is depicted in FIG. 6B. The visual prompt (614) may comprise a graphic that moves along a specified trajectory as an analyte measurement operation is occurring. Specifically, the graphic may be at the beginning of its specified trajectory or path when the user begins the analyte measurement operation, it may be displaced such that it is at the midpoint of its specified trajectory when the analyte measurement operation is half-way completed, and it may be displaced such that it is at the end of its specified trajectory when the analyte measurement operation is complete. For example, FIG. 6B depicts a racecar (612) exiting a ramp (610) and completing a rotation in the air. In this example, the racecar (612) may appear on the device (600) when a user begins a testing sequence. The racecar (612) may move vertically and horizontally along a specified trajectory while the testing sequence is taking place such that the racecar's (612) movement tracks the progress of the testing sequence. For example, the racecar (612) may begin exiting the ramp (610) when the user begins the test sequence, the racecar (612) may have rotated 180 degrees when the user is half-way through the test sequence, and the racecar (612) may appear to be landing when the test sequence is complete. The above embodiments are merely examples and any suitable graphical representation could be used.


Customization


As discussed above, the analyte sampling devices may be configured to output a plurality of different prompts. In some variations, the specific prompts outputted by the analyte measurement devices may be customized in one or more ways. Generally, the analyte measurement device is programmed with a plurality of “prompt types.” Each prompt type indicates an instance during which the analyte measurement device may output a prompt. For example, an analyte measurement device may be configured with a first prompt type (e.g., providing a prompt when the device is powered on or awoken from a low-power sleep state), a second prompt type (e.g., providing a prompt when a user has performed a given number of consecutive tests in a given time frame), and a third prompt type (e.g., providing a prompt when the device has completed an analyte measurement operation). For each prompt type, the analyte measurement device may be programmed with one or more prompts that may be selected for that prompt type. The analyte measurement device may be figured to select a prompt for each prompt type, and these selections are collectively referred to as a prompt set. It may be possible for a user or the device to select from one of a plurality of possible prompt sets, and the currently selected prompt set is referred to here as the active prompt set. The active prompt set may be manually set by a user, or may be automatically determined by the analyte measurement device, as will be discussed in more detail below. While typically a single prompt is selected for each prompt type of a prompt set, in some instances a plurality of different prompts may be selected for a given prompt type in a prompt set. In these instances, when the analyte measurement device determines that conditions for outputting the prompt type have been met, the device may select one of the plurality of different prompts in a random or predetermined order. Additionally, for the purposes of this application, when a specific prompt of a prompt type is intended to convey a measurement or time (e.g., a concentration of an analyte in a sample, the duration of time that has passed between measurements, the number of consecutive days the device has performed a testing operation, the current time, etc.), the prompt is considered a single prompt even though the actual measurement or time conveyed by the prompt may vary depending between instances that the prompt is output.


When two or more prompts are used for a given prompt type, the prompts may vary in any suitable manner. In some variations, a prompt type may have auditory prompt variations where different language is used (e.g., “Welcome to POGO®” in a first variation, “Let's test your glucose!” in a second variation). In other variations, a prompt type may have visual prompt variations where different graphics are used (e.g., a sun-rising in a first variation, a bowl of cereal in a second variation). In some embodiments, a prompt type may have an auditory prompt, a visual prompt and a tactile prompt associated with it. In embodiments in which multiple prompts (e.g., visual, auditory, tactile) are associated with a prompt type, and the prompt type comprises prompt variations (e.g., 2 different visual prompts, 2 different auditory prompts), any combination of the prompts may be used and the combinations may be selected in any suitable manner (e.g. by the user, at random, etc.).


Specifically with respect to auditory prompts, a prompt may have variations where different voices are used (e.g., a female voice in a first variation and a male voice in a second variation). Additionally or alternatively, a prompt may have variations where different sound effects are associated with a prompt (e.g., when a prompt gives positive reinforcement for frequent testing, such as “Way to go! You've tested 4 days in a row,” a first variation may include the sounds of a cheering crowd while a second variation may include a fanfare of trumpets).


In some variations, the device may be configured to allow a user to record one or more auditory prompts. For example, when an analyte measurement device will be used by a child, it may be desirable for the device to output auditory prompts that have been recorded by a parent or caretaker of the child. Providing auditory prompts with a familiar voice may provide an added level of comfort to the child as he or she uses the device, which may reduce fear associated with the device and may encourage the child to test more frequently. The recorded auditory prompts may be provided to the analyte measurement device in any suitable manner. In some variations, the auditory prompts may be recorded by the user on an external device (e.g., a computer, phone, tablet, recorder, or the like), and may be transmitted to the analyte measurement device (e.g., using a physical connection such as a USB connection and/or a wireless connection such as WiFi or RFID, as discussed in more detail above). In these variations, the external device may comprise a program that has a prompt recording mode configured to facilitate recording of specific auditory prompts, as will be discussed in more detail below.


In other variations, the analyte measurement device may be configured to record one or more auditory prompts. In these variations, the analyte measurement device may comprise a microphone or other sound recording device configured to capture a user's voice. Additionally, the analyte measurement device may be programmed with a prompt recording mode. When the device is placed in the prompt recording mode, the device may be configured to guide the user through recording one or more voice prompts. The prompt recording mode may be initiated during initial setup of the analyte measurement device, or may be selectively initiated by a user (e.g., through a menu command). The analyte measurement device may be configured to automatically guide the user through recording a predetermined number of auditory prompts (such as, for example, a given prompt set), or the user may select which auditory prompts he or she would like to record. For each auditory prompt that will be recorded in the prompt recording mode, the analyte measurement device may be configured to identify what prompt or prompt type will be recorded (e.g., “Please say a few words of encouragement”, “Please repeat the following when instructed: ‘Good morning!’”), instruct the user when to start and/or stop recording (e.g., “Please begin recording after the countdown, and press the power button when you have finished. 3, 2, 1.”). When the auditory prompt has been recorded, the prompt recording mode may be configured to associate the recorded prompt with one or more prompt types (and in some instances, one or more prompt sets).


In some variations where an analyte measurement device may be used by multiple users, the device may be configured to select a different active prompt set for different users of the device. For example, one or more prompt types may include one or more prompts that are customized to a specific user. For example, when a prompt type is configured to provide an analyte measurement value, an active prompt set for a first user may output a first variation of an auditory prompt (e.g., “John, your blood glucose is 85 mg/mmol”) or a visual prompt (e.g., a cheering man), while an active prompt set for a second user may output a second variation of an auditory prompt (e.g., “Sally, your blood glucose is 85 mg/mmol”) or a visual prompt (e.g., a cheering woman). In some variations, prompts may be tailored to a given user, and may use information about that user (e.g., by using the user's name, the name of the user's physician, etc.). Additionally or alternatively, the prompts may be selected by the user based on his/her preferences (e.g., some users may prefer a male voice while other users may prefer a female voice). In some variations, prompts may be tailored to a given user using information from a user profile setup by the user, as was discussed above.


Generally, the analyte measurement device may be configured to store a user-specific prompt set for a plurality of individual users. When the device determines that one of the plurality of individual users is using the device, the device may be configured to automatically set the user-specific prompt set associated with that user as the active prompt set. In some variations, the analyte measurement device may be configured to select or load a specific prompt set based on information stored in a user's user profile. If the device is being used by an unrecognized user, the device may be configured to set a default prompt set as the active prompt set. Individual users may change their user-specific prompt set (e.g., using menu features or changing it in their user profiles), and new users may be added to the plurality of individual users. The analyte measurement device may be configured to differentiate between users in any suitable manner. In some variations, users may log into or otherwise input an identification code to the analyte measurement device to access or indicate to the device to access their user profiles. In some of these variations, a user may be required to log-in before the device may be used in an analyte measurement operation. Additionally or alternatively, a user may insert a USB stick, memory card, or the like into the analyte measurement device and the device may determine the user's identity from this component. Additionally or alternatively, a user may carry a key fob or other external device that may be wirelessly detected by the analyte measurement device to determine the user.


Removable or Additional Components


In some variations, the analyte measurement device may select an active prompt set (or a default active prompt set) based on one or more components of the device. In some instances, an analyte measurement device may be constructed and/or manufactured such the analyte measurement device may have one of a plurality of different physical appearances. For example, when the analyte measurement device comprises an outer housing (such as the meter housing (118) of the meter (100) discussed above with respect to FIG. 1B), the outer housing may be altered to change the physical appearance of the analyte measurement device. For example, the surface contours and/or the colors of the outer housing may alter the physical appearance of the analyte measurement device. Similarly, an outer housing may be configured with one or more visual patterns (e.g., chevron pattern, polka dots, etc.) and/or images (e.g., an animal, a race car, or the like).


Accordingly, in some variations, an analyte measurement device may be constructed and/or manufactured in one of a plurality of different configurations, in which each configuration has a different physical appearance. In some of these variations, each configuration of the analyte measurement device may have a default active prompt set associated with that configuration. Accordingly, systems and kits may include a plurality of analyte measurement devices having different physical appearances, each having an appearance-specific default active prompt set. In some instances, the default active prompt set for a given configuration of the device may be thematically associated with the physical appearance of the analyte measurement device. For example, one or more portions of the housing of one configuration of an analyte measurement device may include an image of a car, and the associated auditory prompt set may include car-related sound effects (e.g., revving engines, squealing tires) and/or speech (e.g., “Start your engines”) and/or the associated visual prompt set may include car-related visual effects (e.g. driver in car turning key, rotating tires). Another configuration may include an image of a cat, and the associated auditory prompt set may include cat-related sound effects (e.g., purring, meowing) and/or speech (e.g., “That test was purr-fect”) and/or the associated visual prompt set may include cat-related visual effects (e.g., person petting cat, cat appearing to speak). The analyte measurement devices may have any suitable number of different configurations, each having a graphic appearance and an associated set of prompts.


In some variations, a user may replace one or more components of the analyte measurement device and/or add one or more additional components to alter the physical appearance of the device. In some variations, the analyte measurement device may be configured to change the active prompt set in response to the replacement or addition of one of these components. In some instances, a portion of a housing of the analyte measurement device may be releasably attached to the analyte measurement device such that the releasable portion may be replaced with another variation of the releasable portion. In other variations, the housing may be configured to accept an additional component using snap fit connectors, sliding connectors, clips, or the like. Systems or kits may include a single removable housing portion or they may include a plurality of removable housing portions. In systems or kits that include a plurality of removable housing portions, the analyte measurement device may be configured such that one of the plurality of removable housing portions may be connected to the analyte measurement device at a time. The plurality of removable housing portions may have different physical appearances, such as described above, such that changing the removable housing portion of the analyte measurement device may change the appearance of the analyte measurement device. In some variations, changing the removable housing portion of the device may not significantly change the physical appearance of the device, but may still change the active prompt set. In some instances, the removable or additional housing portion may allow for the delivery of data to the device, for example, updated software or firmware.


In some embodiments, the removable portion of the housing may be a front cover of the housing. For example, in the variation of the device shown in FIG. 1B, the meter housing (118) may comprise a removable front cover (132). In other variations, a front cover may be added to the housing. For example, in the variation of the analyte measurement device (700) shown in FIG. 7A, the housing (702) may comprise a first front cover (704) and may be configured to accept a second front cover (706). The second front cover (706) may alter the physical appearance of the device, change the active prompt set and/or deliver data stored within it to the device. In other embodiments, the removable portion of the housing may be a component other than the front cover. For example, as shown in FIGS. 7A and 7B, the removable portion of the housing may comprise the bottom (708), the port (710), the battery cover (712), the back cover (714), and the like.


In some embodiments, the cartridge may be configured to carry information relating to a prompt set. The cartridge (102) may comprise an information storage member (134) that carries information and may communicate with the meter (100) to convey the stored information. For example, the storage information member (134) may comprise one or more barcodes, as depicted in FIG. 1C. In these variations, the meter (100) may comprise one or more barcode scanners/readers. In variations where the cartridges are cylindrical or have an otherwise rounded cross-sectional area, the cartridge may be rotated to facilitate the reading of the barcode. In other instances, the meter (100) may be configured to move the cartridge into a position where the barcode may be read.


The cartridge may comprise any suitable number of barcodes (e.g., zero, one, two, three, or four or more barcodes). In some variations, the information storage member (134) may comprise one or more memory chips or cards, which may convey information to the meter through, for example, RF transmission, optical communication, or via direct electrical communication. In other variations, a separate memory card or chip may be packaged and/or provided with the cartridge. This memory card or chip may be inserted into a portion of the meter to convey information to the meter, as is discussed in more detail below.


As mentioned above, the analyte measurement device may be configured to change the active prompt set based on the removable portion that is currently connected to the analyte measurement device. In some variations, the analyte measurement device may be configured to automatically detect which removable portion is connected to the device and select an active prompt set associated with that removable portion. In some embodiments, the removable portion may comprise an identifier that may contain or transmit information or otherwise communicate with the analyte measurement device about the removable component connected to it and/or the prompt set (e.g., auditory, visual, etc.) associated with the connected removable component. For example, a system may comprise an analyte measurement device configured to receive a removable housing portion, and may further comprise a first version of the removable housing portion and a second version of the removable housing portion. The first version of the removable housing portion may have a first prompt set associated therewith, and the second version of the removable housing portion may have a second prompt set associated therewith. When the first version of the removable housing portion is attached to the analyte monitor, the analyte measurement device may be configured to detect the first version's identifier and set the first prompt set as the active prompt set. A user may remove the first version of the removable housing portion and connect the second version of the removable housing portion to the analyte measurement device. Upon connection of the second version of the removable housing portion, the analyte measurement device may detect the second version's identifier and may set the second prompt set as the active prompt set. In some variations, the identifier may be integrally formed with the prompt set.


Systems and kits may include a single removable housing portion or a plurality of versions of a given removable housing portion. Each version of the plurality of versions may have an associated identifier and prompt set, and the analyte measurement device may be configured to detect the version of the removable housing portion and set the associated prompt set as the active prompt set. In some variations, each version of the removable housing portion may include a different prompt set. A first prompt set may be considered different from a second prompt set if at least one prompt within the prompt set is different or if the prompt sets comprise different numbers of prompts.


Additionally or alternatively, as depicted in FIGS. 8A-8B, a skin (802) (e.g. a silicone case or the like) may be placed over and connected to a portion of the housing (804) of an analyte measurement device (800), which may change the physical appearance of the analyte measurement device (800). In these variations, the analyte measurement device (800) may be configured to detect the presence of an identifier in/on the skin (802), and may be configured to set a prompt set (auditory, visual, etc.) associated with the skin (802) as the active prompt set. In some instances, a system or kit may comprise a skin (802) comprising an identifier that is associated with a prompt set. In other variations, a system or kit may comprise multiple versions of a skin (802) (e.g., having different physical appearances or configurations), wherein each version comprises an identifier with a prompt set associated therewith. In these variations, the analyte measurement device may be configured to detect which version of the skin (802) is connected to the device (800) using the identifier, and may set the prompt set associated with that identifier as the active prompt set. For example, a system may include an analyte measurement device, a first version of a skin having a first prompt set associated therewith, and a second version of the skin having a second prompt set associated therewith. The skins may have different physical appearances, such as discussed above. In these variations, when the first skin is attached to the analyte measurement device, the analyte measurement device may be configured to detect the first skin's identifier and set the first prompt set as the active prompt set. A user may remove the first version and connect the second version of the skin to the analyte measurement device. In these instances, the analyte measurement device may be configured to detect the second skin's identifier and may set the second prompt set as the active prompt set. In some variations, the identifier may be integrally formed with the prompt set.


In variations where an analyte measurement device is configured to receive both a removable portion of a housing and a skin, the analyte measurement device may be configured to select the set of auditory prompts based on either the version of the removable portion or the version of the skin. In some of these variations, the presence of a skin may override the presence of the removable portion, such that the analyte measurement device is configured to set a prompt set associated with the skin as the active prompt set instead of a prompt set associated with the removable portion when both the skin and the removable portion are present. In some instances a user may be able to change the active prompt set even when a specific version of a skin or removable housing portion is attached to an analyte measurement device, by for example, changing a selection in a menu on the device.


The analyte measurement device may be configured to detect the identifier of a removable housing portion and/or a skin in any suitable manner. In some variations, a removable housing portion/skin may be configured to achieve direct electrical communication with a control unit of the analyte measurement device when attached to the analyte measurement device. For example, the removable housing portion or skin may include an electrical interface (such as a USB interface) that may physically contact an electrical interface of the analyte measurement device, and the analyte measurement device may be able to recognize or determine the presence and/or identifier of the removable housing portion/skin based on this electrical connection. Additionally or alternatively, one or more portions of the removable housing portion/skin may physically press against one or more buttons of the analyte measurement device to indicate the presence and/or identifier of a removable housing portion/skin. Additionally or alternatively, the removable housing portion/skin may be configured to wirelessly communicate with the analyte measurement device (e.g., via WiFi or RFID) such that the analyte measurement device may be configured to recognize or determine the presence and/or identifier of a removable housing portion/skin.


When the analyte measurement device is configured to set an active prompt set based on a prompt set corresponding to a removable housing portion's or skin's identifier, the specific prompts from the prompt set may be retrieved from any suitable location. In some variations, the analyte measurement device may be pre-programmed with the necessary prompts included in the various prompt sets. For example, if a system includes an analyte measurement device and a plurality of versions of a removable housing portion, each version having a corresponding prompt set, the analyte measurement device may be pre-programmed with the auditory prompts of each of the corresponding prompts. Additionally or alternatively, the analyte measurement device may be configured to retrieve one or more prompts from the removable housing portion/skin. In these variations, the removable housing portion/skin may be configured to store one or more prompts or prompt sets (e.g., in a memory such as flash memory or an integrated circuit), and the analyte measurement device may be configured to retrieve the prompts or prompt sets from the removable housing portion/skin. In some of these variations, the analyte measurement device may be configured to retrieve and use the prompts from the removable housing portion/skin without permanently storing the prompts in memory of the analyte measurement device. In other variations, the analyte measurement device may be configured to download and store the prompts from the removable portion/skin. In these variations, the downloaded prompts may be later selected (e.g., by a user) for use even when the specific version of the removable housing portion/skin has been removed from the analyte measurement device, using, for example, a selection menu. In still other variations, prompts or prompt sets associated with versions of a removable housing portion/skin may be downloaded from an external device (e.g., a computer, tablet, phone in communication with the analyte measurement device, a memory stick that may be inserted into the analyte measurement device, etc.) either via direct connection (such as a USB interface) or wireless connection (e.g., WiFi, RFID). In some variations, the removable housing portion/skin may contain updated software/firmware that may be transferred to the device when the removable housing portion/skin communicates with the device. The software/firmware updates may be contained on the removable housing portion/skin in addition to, or instead of, the prompt sets.


As mentioned above, the analyte measurement device may comprise a variety of components that enable the transfer of information from a removable housing portion/skin to the control unit of the device. FIG. 7C depicts a variation of the analyte measurement devices described here with the back cover (714) removed. In this embodiment, the analyte measurement device (700) may comprise electrical contacts (716) located below the batteries when the device is in use. The electrical contacts (716) may be configured to mate or otherwise communicate with corresponding electrical contacts on a removable housing portion, for example, a battery cover (712). Alternatively or additionally, the device (800) may comprise one or more wireless chips (718) that may communicate with one or more corresponding wireless chips contained in or on a removable portion of the device. In some embodiments, the device (800) may also comprise a USB port (720) that may physically contact a USB plug on the removable portion of the device. These components may mate with any removable or additional portion of the housing or with a skin, as described above.



FIGS. 8A-8D illustrate another variation of the analyte measurement devices described here. FIGS. 8A and 8B depict front and perspective views of an analyte measurement device (800) with a skin (802) partially covering the housing (804). FIGS. 8C-8D depict a top perspective view of an analyte measurement device (800) without a skin (802), and with a skin partially covering the housing (804), respectively. The analyte measurement device (800) shown here may receive information from the replacement or addition of a skin (802). The skin (802) may comprise any suitable means for storing and transferring information. For example, the skin (802) may comprise a chip (806) that may store information and transfer it to the control unit of the device (800). In some variations, the skin may comprise a USB plug (808) that may physically contact a USB port (810) on the device (800). While the USB port (810) is depicted on the top of the device (800), it may be placed at any location that is suitable for connection to a skin (802) or other removable or additional housing portion. In some variations, the skin (802) may comprise both a USB plug (808) and a USB port (812) such that attachment of the skin (802) to the device (800) does not prevent the device (800) from connecting via USB to another component.

Claims
  • 1. A system comprising: an analyte quantification member configured to react with an analyte in a fluid sample to produce a measureable response; andan analyte measurement device configured to detect the measureable response and determine a concentration of the analyte, wherein the analyte measurement device comprises: a housing comprising a releasable housing portion, wherein the releasable housing portion comprises an information transmitter that is associated with an auditory prompt set;a speaker disposed within the housing; anda control unit disposed within the housing, wherein the control unit comprises: a non-transitory memory comprising instructions to detect the information transmitter, set the auditory prompt set associated with the detected information transmitter as an active prompt set, and output the active prompt set via the speaker, wherein the auditory prompt set associated with the releasable housing portion comprises an auditory prompt that warns a user of an impending lance with a skin penetration member by indicating an expiring time period until the lance occurs, and an auditory prompt that alerts a user that the analyte measurement device has acquired a usable sample; anda processor programmed to carry out the instructions on the non-transitory memory.
  • 2. The system of claim 1 wherein the system further comprises a plurality of releasable housing portions.
  • 3. The system of claim 2 wherein each of the releasable housing portions is associated with an auditory prompt set comprising at least one auditory prompt that differs from at least one auditory prompt associated with the other releasable housing portions of the plurality of releasable housing portions.
  • 4. The system of claim 1 wherein the auditory prompt set associated with the releasable housing portion is stored on the non-transitory memory.
  • 5. The system of claim 1 wherein the releasable housing portion further comprises a non-transitory memory, and wherein the auditory prompt set associated with the releasable housing portion is stored on the non-transitory memory of the releasable housing portion.
  • 6. The system of claim 1 wherein the auditory prompt set associated with the releasable housing portion is stored on a server system, and wherein the non-transitory memory further comprises instructions to retrieve the auditory prompt set from the server system.
  • 7. The system of claim 1 wherein the control unit further comprises a speech unit and wherein the instructions to output the active prompt set comprise instructions to transmit a signal associated with the active prompt set from the speech unit to the speaker.
  • 8. The system of claim 1 wherein the analyte measurement device further comprises a display.
  • 9. The system of claim 1 wherein the analyte measurement device further comprises a microphone.
  • 10. The system of claim 1 wherein the analyte measurement device is configured to collect and analyze a plurality of fluid samples.
  • 11. The system of claim 1 wherein the system further comprises a cartridge containing a plurality of analyte quantification members.
  • 12. The system of claim 1 wherein the releasable housing portion comprises at least one of a front cover, a back cover, and a battery cover.
  • 13. The system of claim 1 wherein the non-transitory memory comprises instructions to detect the information transmitter and set the auditory prompt set associated with the detected information transmitter as the active prompt set automatically.
  • 14. The system of claim 1 wherein the information transmitter comprises a chip configured to wirelessly communicate with the control unit.
  • 15. The system of claim 1 wherein the information transmitter comprises a USB device.
  • 16. The system of claim 1 wherein the instructions to detect the information transmitter comprise instructions to detect an electrical connection between the analyte measurement device and the information transmitter.
  • 17. The system of claim 1 wherein the instructions to detect the information transmitter comprise instructions to detect physical contact between the analyte measurement device and the information transmitter.
  • 18. A system comprising: an analyte quantification member configured to react with an analyte in a fluid sample to produce a measureable response; andan analyte measurement device configured to detect the measureable response and determine a concentration of the analyte, wherein the analyte measurement device comprises: a housing;a speaker disposed within the housing; anda control unit disposed within the housing, wherein the control unit comprises: a non-transitory memory comprising instructions to output an auditory prompt set via the speaker, wherein the auditory prompt set comprises an alert that warns a user of an impending lance with a skin penetration member by indicating an expiring time period until the lance occurs, and an alert that the analyte measurement device has acquired a usable sample; anda processor programmed to carry out the instructions on the non-transitory memory.
  • 19. The system of claim 18 wherein the auditory prompt set is stored on the non-transitory memory.
  • 20. The system of claim 18 wherein the auditory prompt set is stored on a server system, and wherein the non-transitory memory further comprises instructions to retrieve the auditory prompt set from the server system.
  • 21. The system of claim 18 wherein the control unit further comprises a speech unit and wherein the instructions to output the auditory prompt set comprise instructions to transmit a signal associated with the auditory prompt set from the speech unit to the speaker.
  • 22. The system of claim 18 wherein the analyte measurement device further comprises a microphone.
  • 23. The system of claim 18 wherein the analyte measurement device is configured to collect and analyze a plurality of fluid samples.
  • 24. The system of claim 18 wherein the system further comprises a cartridge containing a plurality of analyte quantification members.
  • 25. The system of claim 18 wherein the auditory prompt set further comprises an instruction to position a sampling site relative to a test port of the analyte measurement device.
  • 26. The system of claim 18 wherein the auditory prompt set further comprises an alert that the concentration of the analyte in the fluid sample has been obtained.
  • 27. The system of claim 18 wherein the auditory prompt set comprises an instruction to apply additional sample to the analyte measurement device.
  • 28. The system of claim 18 wherein the non-transitory memory further comprises instructions to output the auditory prompt set via the speaker in response to a single action taken by the user.
  • 29. The system of claim 28 wherein the single action taken by the user is initiating an analyte measurement operation.
  • 30. The system of claim 18 wherein the analyte measurement device further comprises a display.
  • 31. The system of claim 30 wherein the non-transitory memory further comprises instructions to output the auditory prompt set and a visual prompt set on the display simultaneously.
  • 32. The system of claim 31 wherein the visual prompt set comprises a graphical representation of one or more steps of a sampling process.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application Ser. No. 61/838,171, filed on Jun. 21, 2013, which is hereby incorporated by reference in its entirety.

US Referenced Citations (630)
Number Name Date Kind
842690 Oswalt Jan 1907 A
D137874 Partridge May 1944 S
2749797 Harks Mar 1950 A
3092465 Adams, Jr. Jun 1963 A
3310002 Wilburn Mar 1967 A
3620209 Kravitz Nov 1971 A
3623475 Sanz et al. Nov 1971 A
3626929 Sanz et al. Dec 1971 A
3630957 Rey Dec 1971 A
D223165 Komendat Mar 1972 S
3723064 Liotta Mar 1973 A
3741197 Sanz et al. Jun 1973 A
3961898 Neeley et al. Jun 1976 A
3992158 Przybylowicz et al. Nov 1976 A
4014328 Cluff et al. Mar 1977 A
4042335 Clement Aug 1977 A
4057394 Genshaw Nov 1977 A
4109655 Chacornac Aug 1978 A
4250257 Lee et al. Feb 1981 A
4253083 Imamura Feb 1981 A
4254083 Columbus Mar 1981 A
4258001 Pierce et al. Mar 1981 A
4260257 Neeley et al. Apr 1981 A
4289459 Neeley et al. Sep 1981 A
4321397 Nix et al. Mar 1982 A
4350762 DeLuca et al. Sep 1982 A
4394512 Batz Jul 1983 A
4414975 Ryder et al. Nov 1983 A
4416279 Lindner et al. Nov 1983 A
4418037 Katsuyama et al. Nov 1983 A
4422941 Vaughan, Jr. et al. Dec 1983 A
4429700 Thees et al. Feb 1984 A
4627445 Garcia et al. Dec 1986 A
4637403 Garcia et al. Jan 1987 A
4637406 Guinn et al. Jan 1987 A
4653513 Dombrowski Mar 1987 A
4661319 Lape Apr 1987 A
4702261 Cornell et al. Oct 1987 A
4711250 Gilbaugh, Jr. et al. Dec 1987 A
4737458 Batz et al. Apr 1988 A
4767415 Duffy Aug 1988 A
4774192 Terminiello et al. Sep 1988 A
4787398 Garcia et al. Nov 1988 A
4790979 Terminiello et al. Dec 1988 A
4794926 Munsch et al. Jan 1989 A
4815843 Tiefenthaler et al. Mar 1989 A
4829470 Wang May 1989 A
4844095 Chiodo et al. Jul 1989 A
4846785 Cassou et al. Jul 1989 A
4887306 Hwang et al. Dec 1989 A
4920977 Haynes May 1990 A
4929426 Bodai et al. May 1990 A
4930525 Palestrant Jun 1990 A
4935346 Phillips Jun 1990 A
4953552 De Marzo Sep 1990 A
4966646 Zdeblick Oct 1990 A
4983178 Schnell Jan 1991 A
4995402 Smith Feb 1991 A
5029583 Meserol Jul 1991 A
5035704 Lambert et al. Jul 1991 A
5049487 Phillips et al. Sep 1991 A
5050617 Columbus et al. Sep 1991 A
5059394 Phillips et al. Oct 1991 A
5077199 Basagni et al. Dec 1991 A
5094943 Siedel et al. Mar 1992 A
5110724 Hewett May 1992 A
5114350 Hewett May 1992 A
5116759 Klainer et al. May 1992 A
5131404 Neeley et al. Jul 1992 A
5141868 Shanks et al. Aug 1992 A
5145565 Kater et al. Sep 1992 A
5146437 Boucheron Sep 1992 A
5153416 Neeley Oct 1992 A
5164575 Neeley et al. Nov 1992 A
5166498 Neeley Nov 1992 A
5174291 Schoonen et al. Dec 1992 A
5176632 Bernardi Jan 1993 A
5179005 Phillips et al. Jan 1993 A
5183741 Arai et al. Feb 1993 A
5196302 Kidwell Mar 1993 A
5208163 Charlton et al. May 1993 A
5213966 Vuorinen et al. May 1993 A
5217480 Habar et al. Jun 1993 A
5218966 Yamasawa Jun 1993 A
5223219 Subramanian et al. Jun 1993 A
5228972 Osaka et al. Jul 1993 A
5234818 Zimmermann et al. Aug 1993 A
5241969 Carson et al. Sep 1993 A
5251126 Kahn et al. Oct 1993 A
D341848 Bigelow et al. Nov 1993 S
5269800 Davis, Jr. Dec 1993 A
5275159 Griebel Jan 1994 A
5278079 Gubinski et al. Jan 1994 A
5279294 Anderson et al. Jan 1994 A
5288646 Lundsgaard et al. Feb 1994 A
5299571 Mastrototaro Apr 1994 A
5301686 Newman Apr 1994 A
5302513 Mike et al. Apr 1994 A
5304468 Phillips et al. Apr 1994 A
5306623 Kiser et al. Apr 1994 A
5308767 Terashima May 1994 A
5314441 Cusack et al. May 1994 A
5320607 Ishibashi Jun 1994 A
5354537 Moreno Oct 1994 A
5360595 Bell et al. Nov 1994 A
5368047 Suzuki et al. Nov 1994 A
5383512 Jarvis Jan 1995 A
5390671 Lord et al. Feb 1995 A
5395388 Schraga Mar 1995 A
5399316 Yamada Mar 1995 A
5401110 Neeley Mar 1995 A
5402798 Swierczek et al. Apr 1995 A
5426032 Phillips et al. Jun 1995 A
5441513 Roth Aug 1995 A
5451350 Macho et al. Sep 1995 A
5458140 Eppstein et al. Oct 1995 A
5460777 Kitajima et al. Oct 1995 A
5460968 Yoshida et al. Oct 1995 A
5482473 Lord et al. Jan 1996 A
5506200 Hirschkoff et al. Apr 1996 A
5507288 Böcker et al. Apr 1996 A
5508200 Tiffany et al. Apr 1996 A
5510266 Bonner et al. Apr 1996 A
5514152 Smith May 1996 A
5525518 Lundsgaard et al. Jun 1996 A
5527892 Borsotti et al. Jun 1996 A
5563042 Phillips et al. Oct 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569287 Tezuka et al. Oct 1996 A
5575403 Charlton et al. Nov 1996 A
5577499 Teves Nov 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5591139 Lin et al. Jan 1997 A
5593838 Zanzucchi et al. Jan 1997 A
5611809 Marshall et al. Mar 1997 A
5624458 Lipscher Apr 1997 A
5630986 Charlton et al. May 1997 A
5632410 Moulton et al. May 1997 A
5636632 Bommannan et al. Jun 1997 A
5647851 Pokras Jul 1997 A
5658515 Lee et al. Aug 1997 A
5660791 Brenneman et al. Aug 1997 A
5670031 Hintsche et al. Sep 1997 A
5676850 Reed et al. Oct 1997 A
5680858 Hansen et al. Oct 1997 A
5681484 Zanzucchi et al. Oct 1997 A
5682233 Brinda Oct 1997 A
5697901 Eriksson Dec 1997 A
5700695 Yassinzadeh et al. Dec 1997 A
5701181 Boiarski et al. Dec 1997 A
5701910 Powles et al. Dec 1997 A
D389761 Thomas Jan 1998 S
5705018 Hartley Jan 1998 A
5708247 McAleer Jan 1998 A
5708787 Nakano et al. Jan 1998 A
5715417 Gardien et al. Feb 1998 A
5730753 Morita Mar 1998 A
5735273 Kurnik et al. Apr 1998 A
5736103 Pugh Apr 1998 A
5741211 Renirie et al. Apr 1998 A
5746217 Erickson et al. May 1998 A
5746720 Stouder, Jr. May 1998 A
5757666 Schreiber et al. May 1998 A
5759364 Charlton et al. Jun 1998 A
5766066 Ranniger Jun 1998 A
5771890 Tamada Jun 1998 A
5797693 Jaeger Aug 1998 A
5800420 Gross et al. Sep 1998 A
5801057 Smart et al. Sep 1998 A
5807375 Gross et al. Sep 1998 A
5820570 Erickson et al. Oct 1998 A
5827183 Kurnik et al. Oct 1998 A
5840020 Heinonen et al. Nov 1998 A
5841126 Fossum et al. Nov 1998 A
5843692 Phillips et al. Dec 1998 A
5846837 Thym et al. Dec 1998 A
5851215 Mawhirt et al. Dec 1998 A
5854074 Charlton et al. Dec 1998 A
D403975 Douglas et al. Jan 1999 S
5855801 Lin et al. Jan 1999 A
5856195 Charlton et al. Jan 1999 A
5858194 Bell Jan 1999 A
5866281 Guckel et al. Feb 1999 A
5871494 Simons et al. Feb 1999 A
5879310 Sopp et al. Mar 1999 A
5879326 Godshall et al. Mar 1999 A
5879367 Latterell et al. Mar 1999 A
5885839 Lingane et al. Mar 1999 A
5891053 Sesekura Apr 1999 A
5893870 Talen et al. Apr 1999 A
D411621 Eisenbarth et al. Jun 1999 S
5911711 Pelkey Jun 1999 A
5911737 Lee et al. Jun 1999 A
5912139 Iwata et al. Jun 1999 A
5925021 Castellano et al. Jul 1999 A
5928207 Pisano et al. Jul 1999 A
5930873 Wyser Aug 1999 A
5938679 Freeman et al. Aug 1999 A
5945678 Yanagisawa Aug 1999 A
5951492 Douglas et al. Sep 1999 A
5951493 Douglas et al. Sep 1999 A
5951521 Mastrototaro et al. Sep 1999 A
5954685 Tierney Sep 1999 A
5962215 Douglas et al. Oct 1999 A
5968760 Phillips et al. Oct 1999 A
5968765 Grage et al. Oct 1999 A
5968836 Matzinger et al. Oct 1999 A
5971941 Simons et al. Oct 1999 A
5972294 Smith et al. Oct 1999 A
5986754 Harding Nov 1999 A
5989409 Kurnik et al. Nov 1999 A
5993189 Mueller et al. Nov 1999 A
D417504 Love et al. Dec 1999 S
6001067 Shults et al. Dec 1999 A
6005545 Nishida et al. Dec 1999 A
6010463 Lauks et al. Jan 2000 A
6010519 Mawhirt et al. Jan 2000 A
6014135 Fernandes Jan 2000 A
6014577 Henning et al. Jan 2000 A
6023629 Tamada Feb 2000 A
6027459 Shain et al. Feb 2000 A
6030827 Davis et al. Feb 2000 A
6032059 Henning et al. Feb 2000 A
6036924 Simons et al. Mar 2000 A
6041253 Kost et al. Mar 2000 A
6045753 Loewy et al. Apr 2000 A
6048352 Douglas et al. Apr 2000 A
6050988 Zuck Apr 2000 A
6056701 Duchon et al. May 2000 A
6056734 Jacobsen et al. May 2000 A
6058321 Swayze et al. May 2000 A
6059815 Lee et al. May 2000 A
6061128 Zweig et al. May 2000 A
6063039 Cunningham et al. May 2000 A
6071251 Cunningham et al. Jun 2000 A
6071294 Simons et al. Jun 2000 A
6077660 Wong et al. Jun 2000 A
6080116 Erickson et al. Jun 2000 A
6083196 Trautman et al. Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6090790 Eriksson Jul 2000 A
6091975 Daddona et al. Jul 2000 A
6093156 Cunningham et al. Jul 2000 A
6097831 Wieck et al. Aug 2000 A
6099484 Douglas et al. Aug 2000 A
6100107 Lei et al. Aug 2000 A
6102933 Lee et al. Aug 2000 A
6103033 Say et al. Aug 2000 A
6103197 Werner Aug 2000 A
6106751 Talbot et al. Aug 2000 A
6118126 Zanzucchi Sep 2000 A
6120676 Heller et al. Sep 2000 A
6123861 Santini, Jr. et al. Sep 2000 A
6126899 Woudenberg et al. Oct 2000 A
6132449 Lum et al. Oct 2000 A
6139562 Mauze et al. Oct 2000 A
6142939 Eppstein et al. Nov 2000 A
6152942 Brenneman et al. Nov 2000 A
6162639 Douglas Dec 2000 A
6172743 Kley et al. Jan 2001 B1
6175752 Say et al. Jan 2001 B1
6176865 Mauze et al. Jan 2001 B1
6183434 Eppstein et al. Feb 2001 B1
6183489 Douglas et al. Feb 2001 B1
6187210 Lebouiz et al. Feb 2001 B1
6192891 Gravel et al. Feb 2001 B1
6193873 Ohara et al. Feb 2001 B1
6200296 Dibiasi et al. Mar 2001 B1
6206841 Cunningham et al. Mar 2001 B1
6214626 Meller et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6228100 Schraga May 2001 B1
6230051 Cormier et al. May 2001 B1
6231531 Lum et al. May 2001 B1
6241862 McAleer et al. Jun 2001 B1
6242207 Douglas et al. Jun 2001 B1
6245215 Douglas et al. Jun 2001 B1
6251083 Yum et al. Jun 2001 B1
6251260 Heller et al. Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6255061 Mori et al. Jul 2001 B1
6256533 Yuzhakov et al. Jul 2001 B1
6268162 Phillips et al. Jul 2001 B1
6271045 Douglas et al. Aug 2001 B1
6272364 Kurnik Aug 2001 B1
6283926 Cunningham et al. Sep 2001 B1
6289230 Chaiken et al. Sep 2001 B1
6298254 Tamada Oct 2001 B2
6299578 Kurnik et al. Oct 2001 B1
6299757 Feldman et al. Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309351 Kurnik et al. Oct 2001 B1
D450711 Istvan et al. Nov 2001 S
6312612 Sherman et al. Nov 2001 B1
6312812 Sherman et al. Nov 2001 B1
6312888 Wong et al. Nov 2001 B1
6315738 Nishikawa et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6329161 Heller et al. Dec 2001 B1
6331266 Powell et al. Dec 2001 B1
6332871 Douglas et al. Dec 2001 B1
6334856 Allen et al. Jan 2002 B1
6350273 Minagawa et al. Feb 2002 B1
6352514 Douglas et al. Mar 2002 B1
6356776 Berner et al. Mar 2002 B1
6358265 Thorne, Jr. et al. Mar 2002 B1
6364890 Lum et al. Apr 2002 B1
6375626 Allen et al. Apr 2002 B1
6375627 Mauze et al. Apr 2002 B1
6379969 Mauze et al. Apr 2002 B1
6391005 Lum et al. May 2002 B1
6391645 Huang et al. May 2002 B1
6402704 McMorrow Jun 2002 B1
6409679 Pyo Jun 2002 B2
6428664 Bhullar et al. Aug 2002 B1
6449608 Morita et al. Sep 2002 B1
6455324 Douglas Sep 2002 B1
6493069 Nagashimada Dec 2002 B1
6500134 Cassone Dec 2002 B1
6520973 McGarry Feb 2003 B1
6530892 Kelly Mar 2003 B1
6537243 Henning et al. Mar 2003 B1
6540675 Aceti et al. Apr 2003 B2
6544475 Douglas et al. Apr 2003 B1
6549796 Sohrab Apr 2003 B2
6555061 Leong et al. Apr 2003 B1
6558624 Lemmon et al. May 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6589260 Schmelzeisen-Redeker et al. Jul 2003 B1
6591125 Buse et al. Jul 2003 B1
6602205 Erickson et al. Aug 2003 B1
6612111 Hodges et al. Sep 2003 B1
6616616 Fritz et al. Sep 2003 B2
6626874 Duchamp Sep 2003 B1
6656167 Numao et al. Dec 2003 B2
6679852 Schmelzeisen-Redeker et al. Jan 2004 B1
6706000 Perez et al. Mar 2004 B2
6706049 Moerman Mar 2004 B2
6706159 Moerman et al. Mar 2004 B2
6707554 Miltner et al. Mar 2004 B1
6740800 Cunningham May 2004 B1
6743635 Neel et al. Jun 2004 B2
6748275 Lattner et al. Jun 2004 B2
6753187 Cizdziel et al. Jun 2004 B2
6766817 da Silva Jul 2004 B2
6793633 Douglas et al. Sep 2004 B2
6830669 Miyazaki et al. Dec 2004 B2
6836678 Tu Dec 2004 B2
6837858 Cunningham et al. Jan 2005 B2
6847451 Pugh Jan 2005 B2
6849052 Uchigaki et al. Feb 2005 B2
6896850 Subramanian et al. May 2005 B2
6918404 Da Silva Jul 2005 B2
6919960 Hansen et al. Jul 2005 B2
6923764 Aceti et al. Aug 2005 B2
6936476 Anderson et al. Aug 2005 B1
D511214 Sasano et al. Nov 2005 S
6988996 Roe et al. Jan 2006 B2
7004928 Aceti et al. Feb 2006 B2
7011630 Desai et al. Mar 2006 B2
7025774 Freeman et al. Apr 2006 B2
D519868 Sasano et al. May 2006 S
7052652 Zanzucchi et al. May 2006 B2
7066586 Da Silva Jun 2006 B2
7066890 Lam et al. Jun 2006 B1
7141058 Briggs et al. Nov 2006 B2
7156809 Quy Jan 2007 B2
7163616 Vreeke et al. Jan 2007 B2
7192061 Martin Mar 2007 B2
D540343 Cummins Apr 2007 S
7223365 Von Der Goltz May 2007 B2
7225008 Ward et al. May 2007 B1
7226461 Boecker et al. Jun 2007 B2
7258673 Racchini et al. Aug 2007 B2
D551243 Young Sep 2007 S
7270970 Anderson et al. Sep 2007 B2
7297151 Boecker et al. Nov 2007 B2
7299081 Mace et al. Nov 2007 B2
7343188 Sohrab Mar 2008 B2
7344507 Briggs et al. Mar 2008 B2
7379167 Mawhirt et al. May 2008 B2
7427377 Zanzucchi et al. Sep 2008 B2
D580068 Shigesada et al. Nov 2008 S
D580558 Shigesada et al. Nov 2008 S
D599373 Kobayashi et al. Sep 2009 S
D601257 Berlinger Sep 2009 S
7585278 Aceti et al. Sep 2009 B2
D601444 Jones et al. Oct 2009 S
D601578 Poulet et al. Oct 2009 S
7682318 Alden et al. Mar 2010 B2
D622393 Gatrall et al. Aug 2010 S
7780631 Lum et al. Aug 2010 B2
7803123 Perez et al. Sep 2010 B2
7850621 Briggs et al. Dec 2010 B2
7879058 Ikeda Feb 2011 B2
7887494 Emery et al. Feb 2011 B2
D642191 Barnett et al. Jul 2011 S
7988644 Freeman et al. Aug 2011 B2
8012103 Escutia et al. Sep 2011 B2
8012104 Escutia et al. Sep 2011 B2
8105849 McDevitt et al. Jan 2012 B2
D654926 Lipman et al. Feb 2012 S
8173439 Petrich et al. May 2012 B2
8184273 Dosmann et al. May 2012 B2
8231832 Zanzucchi et al. Jul 2012 B2
8251920 Vreeke et al. Aug 2012 B2
8298255 Conway et al. Oct 2012 B2
8303518 Aceti et al. Nov 2012 B2
8360993 Escutia et al. Jan 2013 B2
8360994 Escutia et al. Jan 2013 B2
8372015 Escutia et al. Feb 2013 B2
8376959 Deck Feb 2013 B2
8382681 Escutia et al. Feb 2013 B2
8391940 Matzinger et al. Mar 2013 B2
D691174 Lipman et al. Oct 2013 S
8574168 Freeman et al. Nov 2013 B2
8702624 Alden Apr 2014 B2
8795201 Escutia et al. Aug 2014 B2
8801631 Escutia et al. Aug 2014 B2
8919605 Lipman et al. Dec 2014 B2
8969097 Emery et al. Mar 2015 B2
9060723 Escutia et al. Jun 2015 B2
9060727 Saikley et al. Jun 2015 B2
9095292 Zanzucchi et al. Aug 2015 B2
9149215 Werner et al. Oct 2015 B2
9366636 Emery et al. Jun 2016 B2
9380974 Litherland et al. Jul 2016 B2
9603562 Aceti et al. Mar 2017 B2
9636051 Emery et al. May 2017 B2
9782114 Reynolds et al. Oct 2017 B2
9833183 Escutia et al. Dec 2017 B2
9839384 Escutia et al. Dec 2017 B2
9897610 Lipman et al. Feb 2018 B2
10226208 Emery et al. Mar 2019 B2
10330667 Lipman et al. Jun 2019 B2
10383556 Lipman et al. Aug 2019 B2
10433780 Escutia et al. Oct 2019 B2
10441205 Litherland et al. Oct 2019 B2
20010001034 Douglas May 2001 A1
20010027277 Klitmose Oct 2001 A1
20010027328 Lum et al. Oct 2001 A1
20010053891 Ackley Dec 2001 A1
20020002326 Causey, III et al. Jan 2002 A1
20020002344 Douglas et al. Jan 2002 A1
20020004640 Conn et al. Jan 2002 A1
20020006355 Whitson Jan 2002 A1
20020016568 Lebel et al. Feb 2002 A1
20020020688 Sherman et al. Feb 2002 A1
20020022934 Vogel et al. Feb 2002 A1
20020023852 McIvor et al. Feb 2002 A1
20020042594 Lum et al. Apr 2002 A1
20020045243 Laska et al. Apr 2002 A1
20020052618 Haar et al. May 2002 A1
20020087056 Aceti et al. Jul 2002 A1
20020136667 Subramanian et al. Sep 2002 A1
20020137998 Smart et al. Sep 2002 A1
20020160520 Orloff et al. Oct 2002 A1
20020168290 Yuzhakov et al. Nov 2002 A1
20020169394 Eppstein et al. Nov 2002 A1
20020169411 Sherman et al. Nov 2002 A1
20020177761 Orloff et al. Nov 2002 A1
20020177764 Sohrab Nov 2002 A1
20020183102 Withers et al. Dec 2002 A1
20020188223 Perez et al. Dec 2002 A1
20020198444 Uchigaki et al. Dec 2002 A1
20030012693 Otillar et al. Jan 2003 A1
20030028087 Yuzhakov et al. Feb 2003 A1
20030028125 Yuzhakov et al. Feb 2003 A1
20030039587 Niermann Feb 2003 A1
20030060730 Perez Mar 2003 A1
20030083685 Freeman et al. May 2003 A1
20030083686 Freeman et al. May 2003 A1
20030105961 Zatloukal et al. Jun 2003 A1
20030116596 Terasawa Jun 2003 A1
20030135166 Gonnelli Jul 2003 A1
20030135333 Aceti Jul 2003 A1
20030143746 Sage Jul 2003 A1
20030153844 Smith et al. Aug 2003 A1
20030153900 Aceti et al. Aug 2003 A1
20030175987 Verdonk et al. Sep 2003 A1
20030206302 Pugh Nov 2003 A1
20030207441 Eyster et al. Nov 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030208140 Pugh Nov 2003 A1
20030211617 Jones Nov 2003 A1
20030211619 Olson et al. Nov 2003 A1
20030212344 Yuzhakov et al. Nov 2003 A1
20030212345 McAllister et al. Nov 2003 A1
20030212347 Sohrab Nov 2003 A1
20030216628 Bortz et al. Nov 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040030353 Schmelzeisen-redeker et al. Feb 2004 A1
20040039303 Wurster et al. Feb 2004 A1
20040049219 Briggs et al. Mar 2004 A1
20040059256 Perez Mar 2004 A1
20040072357 Stiene et al. Apr 2004 A1
20040073140 Douglas Apr 2004 A1
20040092842 Boecker et al. May 2004 A1
20040092995 Boecker et al. May 2004 A1
20040094432 Neel et al. May 2004 A1
20040096959 Stiene et al. May 2004 A1
20040097796 Berman et al. May 2004 A1
20040098009 Boecker et al. May 2004 A1
20040102803 Boecker et al. May 2004 A1
20040122339 Roe et al. Jun 2004 A1
20040132167 Rule et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040155084 Brown Aug 2004 A1
20040157339 Burke et al. Aug 2004 A1
20040178218 Schomakers et al. Sep 2004 A1
20040186394 Roe et al. Sep 2004 A1
20040191119 Zanzucchi et al. Sep 2004 A1
20040202576 Aceti et al. Oct 2004 A1
20040230216 LeVaughn et al. Nov 2004 A1
20040236251 Roe et al. Nov 2004 A1
20040238675 Banaszkiewicz et al. Dec 2004 A1
20040242982 Sakata et al. Dec 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040259180 Burke et al. Dec 2004 A1
20050004494 Perez et al. Jan 2005 A1
20050010134 Douglas et al. Jan 2005 A1
20050015020 LeVaughn et al. Jan 2005 A1
20050027182 Siddiqui et al. Feb 2005 A1
20050038680 McMahon Feb 2005 A1
20050070819 Poux et al. Mar 2005 A1
20050096686 Allen May 2005 A1
20050106713 Phan et al. May 2005 A1
20050109386 Marshall May 2005 A1
20050159678 Taniike et al. Jul 2005 A1
20050187532 Thurau et al. Aug 2005 A1
20050192492 Cho et al. Sep 2005 A1
20050202567 Zanzucchi et al. Sep 2005 A1
20050202733 Yoshimura et al. Sep 2005 A1
20050209518 Sage, Jr. et al. Sep 2005 A1
20050215872 Berner et al. Sep 2005 A1
20050215923 Wiegel Sep 2005 A1
20050245844 Mace et al. Nov 2005 A1
20050255001 Padmaabhan et al. Nov 2005 A1
20050277972 Wong et al. Dec 2005 A1
20060008389 Sacherer et al. Jan 2006 A1
20060036134 Tarassenko et al. Feb 2006 A1
20060052724 Roe Mar 2006 A1
20060064035 Wang et al. Mar 2006 A1
20060079809 Goldberger et al. Apr 2006 A1
20060094985 Aceti et al. May 2006 A1
20060117616 Jones et al. Jun 2006 A1
20060122536 Haar et al. Jun 2006 A1
20060135873 Karo et al. Jun 2006 A1
20060155317 List Jul 2006 A1
20060161078 Schraga Jul 2006 A1
20060178600 Kennedy et al. Aug 2006 A1
20060189908 Kennedy Aug 2006 A1
20060204399 Freeman et al. Sep 2006 A1
20060229533 Hoenes et al. Oct 2006 A1
20060241517 Fowler et al. Oct 2006 A1
20060257993 Mcdevitt et al. Nov 2006 A1
20060259102 Slatkine Nov 2006 A1
20060281187 Emery et al. Dec 2006 A1
20070016104 Jansen et al. Jan 2007 A1
20070017824 Rippeth et al. Jan 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070060842 Alvarez-Icaza et al. Mar 2007 A1
20070078313 Emery et al. Apr 2007 A1
20070078358 Escutia et al. Apr 2007 A1
20070083130 Thomson et al. Apr 2007 A1
20070083131 Escutia et al. Apr 2007 A1
20070093786 Goldsmith et al. Apr 2007 A1
20070112281 Olson May 2007 A1
20070179404 Escutia et al. Aug 2007 A1
20070179405 Emery et al. Aug 2007 A1
20070253531 Okuzawa et al. Nov 2007 A1
20070255181 Alvarez-icaza et al. Nov 2007 A1
20070255302 Koeppel et al. Nov 2007 A1
20080004601 Jennewine et al. Jan 2008 A1
20080012701 Kass et al. Jan 2008 A1
20080046831 Imai et al. Feb 2008 A1
20080064986 Kraemer et al. Mar 2008 A1
20080077048 Escutia et al. Mar 2008 A1
20080119702 Reggiardo May 2008 A1
20080139910 Mastrototaro et al. Jun 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080268485 Guarino et al. Oct 2008 A1
20080269625 Halperin et al. Oct 2008 A1
20090054810 Zanzucchi et al. Feb 2009 A1
20090149717 Brauer et al. Jun 2009 A1
20090149729 Young et al. Jun 2009 A1
20090156923 Power et al. Jun 2009 A1
20090292489 Burke et al. Nov 2009 A1
20090301899 Hodges et al. Dec 2009 A1
20100010374 Escutia et al. Jan 2010 A1
20100021947 Emery et al. Jan 2010 A1
20100021948 Lipman et al. Jan 2010 A1
20100095229 Dixon et al. Apr 2010 A1
20100174211 Frey et al. Jul 2010 A1
20100185120 Sacherer et al. Jul 2010 A1
20100217155 Poux et al. Aug 2010 A1
20100331650 Batman et al. Dec 2010 A1
20110098599 Emery et al. Apr 2011 A1
20110105872 Chickering et al. May 2011 A1
20110201909 Emery et al. Aug 2011 A1
20120166090 Lipman et al. Jun 2012 A1
20120271197 Castle Oct 2012 A1
20120296179 Zanzucchi et al. Nov 2012 A1
20130110516 Abulhaj et al. May 2013 A1
20130158430 Aceti et al. Jun 2013 A1
20130158432 Escutia et al. Jun 2013 A1
20130172698 Reynolds et al. Jul 2013 A1
20130274568 Escutia et al. Oct 2013 A1
20130274579 Richter et al. Oct 2013 A1
20140012116 Okuyama Jan 2014 A1
20140316301 Escutia et al. Oct 2014 A1
20140336480 Escutia et al. Nov 2014 A1
20150037898 Baldus et al. Feb 2015 A1
20150153351 Lipman et al. Jun 2015 A1
20150212006 Emery et al. Jul 2015 A1
20150238131 Richter Aug 2015 A1
20160038066 Escutia et al. Feb 2016 A1
20160367178 Emery et al. Dec 2016 A1
20170095188 Emery et al. Apr 2017 A1
20170319121 Aceti et al. Nov 2017 A1
20170354355 Emery et al. Dec 2017 A1
20180008178 Reynolds et al. Jan 2018 A1
20180214059 Escutia et al. Aug 2018 A1
20180296143 Anderson et al. Oct 2018 A1
20180310865 Escutia et al. Nov 2018 A1
20190025318 Lipman et al. Jan 2019 A1
20190104976 Reynolds et al. Apr 2019 A1
20190209064 Emery et al. Jul 2019 A1
20190391129 Lipman et al. Dec 2019 A1
Foreign Referenced Citations (213)
Number Date Country
2 201 530 Sep 1997 CA
2 513 465 Aug 2004 CA
197 05 091 Feb 1999 DE
199 22 413 Nov 2000 DE
103 02-501 Aug 2004 DE
0 103 426 Mar 1984 EP
0 256 806 Feb 1988 EP
0 396-016 Nov 1990 EP
0 396-016 Nov 1990 EP
0 397 424 Nov 1990 EP
0 762 311 Mar 1997 EP
0 255-338 Feb 1998 EP
0 849 584 Jun 1998 EP
1 266-607 Dec 2002 EP
1 266-607 Dec 2002 EP
1 369 688 Oct 2003 EP
1 369 688 Oct 2003 EP
1 360-934 Nov 2003 EP
1 360-934 Nov 2003 EP
1 486-766 Dec 2004 EP
1 486-766 Dec 2004 EP
1 529-489 May 2005 EP
1 529-489 May 2005 EP
1 769-735 Apr 2007 EP
1 987 766 Nov 2008 EP
63-305841 Dec 1988 JP
3-63570 Mar 1991 JP
03093189 Apr 1991 JP
7-67861 Mar 1995 JP
7-213925 Aug 1995 JP
9-168530 Jun 1997 JP
9-313465 Sep 1997 JP
9-266889 Oct 1997 JP
9-294737 Nov 1997 JP
10-024028 Jan 1998 JP
10-505258 May 1998 JP
10-508518 Aug 1998 JP
10-318970 Dec 1998 JP
11056822 Mar 1999 JP
11281779 Oct 1999 JP
2000-116629 Apr 2000 JP
2000-126161 May 2000 JP
2000-168754 Jun 2000 JP
2000-254111 Sep 2000 JP
2001-159618 Jun 2001 JP
2001-515203 Sep 2001 JP
2001-305096 Oct 2001 JP
2001-330581 Nov 2001 JP
2002-502045 Jan 2002 JP
2002-085384 Mar 2002 JP
2002-514453 May 2002 JP
2002-168862 Jun 2002 JP
2003-507719 Feb 2003 JP
2003-108679 Apr 2003 JP
2003-180417 Jul 2003 JP
2004-000598 Jan 2004 JP
2004-500948 Jan 2004 JP
2004-117339 Apr 2004 JP
2004-202256 Jul 2004 JP
2004-209266 Jul 2004 JP
2004-519302 Jul 2004 JP
2004-522500 Jul 2004 JP
2004-528936 Sep 2004 JP
2005-503538 Feb 2005 JP
2005-087613 Apr 2005 JP
2006-512969 Apr 2005 JP
3638958 Apr 2005 JP
2005-525149 Aug 2005 JP
2005-237938 Sep 2005 JP
2005-525846 Sep 2005 JP
2005-527254 Sep 2005 JP
2006-506185 Feb 2006 JP
2006-512974 Apr 2006 JP
2006-516723 Jul 2006 JP
2006-521555 Sep 2006 JP
2006-284481 Oct 2006 JP
2006-527013 Nov 2006 JP
2007-054407 Mar 2007 JP
2007-067698 Mar 2007 JP
2007-521031 Aug 2007 JP
2007-527287 Sep 2007 JP
2007-311196 Nov 2007 JP
2007-537804 Dec 2007 JP
2008-125813 Jun 2008 JP
2008-212324 Sep 2008 JP
2009-509645 Mar 2009 JP
2009-509667 Mar 2009 JP
2010-094167 Apr 2010 JP
2012-213477 Nov 2012 JP
WO-8605966 Oct 1986 WO
WO-8800812 Feb 1988 WO
WO-8807666 Oct 1988 WO
WO-9114212 Sep 1991 WO
WO-9413203 Jun 1994 WO
WO-9510223 Apr 1995 WO
WO-9510223 Apr 1995 WO
WO-9604857 Feb 1996 WO
WO-9607907 Mar 1996 WO
WO-9614026 May 1996 WO
WO-9625088 Aug 1996 WO
WO-9715227 May 1997 WO
WO-9729847 Aug 1997 WO
WO-9730344 Aug 1997 WO
WO-9741421 Nov 1997 WO
WO-9742885 Nov 1997 WO
WO-9742888 Nov 1997 WO
WO-9743962 Nov 1997 WO
WO-9800193 Jan 1998 WO
WO-9831275 Jul 1998 WO
WO-9835225 Aug 1998 WO
WO-9912008 Mar 1999 WO
WO-9923492 May 1999 WO
WO-9944508 Sep 1999 WO
WO-9956954 Nov 1999 WO
WO-9958051 Nov 1999 WO
WO-9962576 Dec 1999 WO
WO-0009184 Feb 2000 WO
WO-0013573 Mar 2000 WO
WO-0014269 Mar 2000 WO
WO-0014535 Mar 2000 WO
WO-0018449 Apr 2000 WO
WO-0018449 Apr 2000 WO
WO-0019185 Apr 2000 WO
WO-0036400 Jun 2000 WO
WO-0042422 Jul 2000 WO
WO-0074763 Dec 2000 WO
WO-0074763 Dec 2000 WO
WO-0078208 Dec 2000 WO
WO-0113795 Mar 2001 WO
WO-0116575 Mar 2001 WO
WO-0152727 Jul 2001 WO
WO-0164105 Sep 2001 WO
WO-0164105 Sep 2001 WO
WO-0172220 Oct 2001 WO
WO-0180728 Nov 2001 WO
WO-0185233 Nov 2001 WO
WO-0185233 Nov 2001 WO
WO-0191634 Dec 2001 WO
WO-0191634 Dec 2001 WO
WO-0200101 Jan 2002 WO
WO-0200101 Jan 2002 WO
WO-0249507 Jun 2002 WO
WO-0249509 Jun 2002 WO
WO-0249509 Jun 2002 WO
WO-02078533 Oct 2002 WO
WO-02078533 Oct 2002 WO
WO-02082052 Oct 2002 WO
WO-02082052 Oct 2002 WO
WO-02093144 Nov 2002 WO
WO-02100251 Dec 2002 WO
WO-02100251 Dec 2002 WO
WO-02101359 Dec 2002 WO
WO-02101359 Dec 2002 WO
WO-03007819 Jan 2003 WO
WO-2003030984 Apr 2003 WO
WO-2003066128 Aug 2003 WO
WO-2003066128 Aug 2003 WO
WO-2003070099 Aug 2003 WO
WO-2003071940 Sep 2003 WO
WO-2003071940 Sep 2003 WO
WO-2004045375 Jun 2004 WO
WO-2004045375 Jun 2004 WO
WO-2004062499 Jul 2004 WO
WO-2004062500 Jul 2004 WO
WO-2004062500 Jul 2004 WO
WO-2004064636 Aug 2004 WO
WO-2004085995 Oct 2004 WO
WO-2004085995 Oct 2004 WO
WO-2004091693 Oct 2004 WO
WO-2004091693 Oct 2004 WO
WO-2004105827 Dec 2004 WO
WO-2004105827 Dec 2004 WO
WO-2005006939 Jan 2005 WO
WO-2005006939 Jan 2005 WO
WO-2005009238 Feb 2005 WO
WO-2005013824 Feb 2005 WO
WO-2005018709 Mar 2005 WO
WO-2005018709 Mar 2005 WO
WO-2005018710 Mar 2005 WO
WO-2005018710 Mar 2005 WO
WO-2005084543 Sep 2005 WO
WO-2005084546 Sep 2005 WO
WO-2005084546 Sep 2005 WO
WO-2005085995 Sep 2005 WO
WO-2005112763 Dec 2005 WO
WO-2006138226 Dec 2006 WO
WO-2006138226 Dec 2006 WO
WO-2007041062 Apr 2007 WO
WO-2007041062 Apr 2007 WO
WO-2007041063 Apr 2007 WO
WO-2007041063 Apr 2007 WO
WO-2007041244 Apr 2007 WO
WO-2007041244 Apr 2007 WO
WO-2007041287 Apr 2007 WO
WO-2007041287 Apr 2007 WO
WO-2007041355 Apr 2007 WO
WO-2007041355 Apr 2007 WO
WO-2007108519 Sep 2007 WO
WO-2007112034 Oct 2007 WO
WO-2007112034 Oct 2007 WO
WO-2007131036 Nov 2007 WO
WO-2008027319 Mar 2008 WO
WO-2008027319 Mar 2008 WO
WO-2008062648 May 2008 WO
WO-2009145920 Dec 2009 WO
WO-2009148624 Dec 2009 WO
WO-2009148626 Dec 2009 WO
WO-2011065981 Jun 2011 WO
WO-2011162823 Dec 2011 WO
WO-2012127870 Sep 2012 WO
WO-2013020103 Feb 2013 WO
WO-2014205412 Dec 2014 WO
WO-2018191700 Oct 2018 WO
Non-Patent Literature Citations (192)
Entry
ADA Consensus Development Panel. (Jan.-Feb. 1987). “Consensus Statement on Self-Monitoring of Blood Glucose,” Diabetes Care 10(1):95-99.
ADA (Jan. 1994). “Self-Monitoring of Blood Glucose,” Consensus Statement Diabetes Care 17(1):81-86.
Anonymous. (Sep. 30, 1993). “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.” The New England Journal of Medicine 329(14):977-986.
Anonymous. (Jun. 23, 1998). Taking the “Ouch” Out of Needles: Arrays of “Microneedles” Offer New Techniques for Drug Delivery, Science Daily, located at <http:www.sciencedaily.com/releases/1998/06/980623045850.htm>, last visited Jan. 14, 2014, 3 pages.
Beregszàszi, M. et al. (Jul. 1997). “Nocturnal Hypoglycemia in Children and Adolescents with Insulin-Dependent Diabetes Mellitus: Prevalence and Risk Factors,” J. Pediatrics 131(1 Pt. 1):27-33.
Chase, H.P. et al. (Feb. 2001). “Continuous Subcutaneous Glucose Monitoring in Children with Type 1 Diabetes,” Pediatrics 107(2):222-226.
Clarke, W.L. et al. (Sep.-Oct. 1987). “Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,” Diabetes Care 10(5):622-628.
Collison, M.E. et al. (Sep. 1999). “Analytical Characterization of Electrochemical Biosensor Test Strips for Measurement of Glucose in Low-vol. Interstitial Fluid Samples,” Clinical Chemistry 45(9):1665-1673.
Coster, S. et al. (2000). “Monitoring Blood Glucose Control in Diabetes Mellitus: A Systematic Review.” Health Technology Assessment 4(12):1-93.
Cox, D.J. et al. (Jun. 1997). “Understanding Error Grid Analysis,” Diabetes Care 20(6):911-912.
D'Arrigo, T.D. (Mar. 2000). “GlucoWatch Monitor Poised for Approval,” Diabetes Forecast, 53(3):43-44.
Feldman, B. et al. (2000). “FreeStyle™: A Small-Volume Electrochemical Glucose Sensor for Home Blood Glucose Testing,” Diabetes Technology and Therapeutics, 2(2):221-229.
Johnson, R.N. et al. (Jan. 1998). “Accuracy of Devices Used for Self-Monitoring of Blood Glucose,” Annals of Clinical Biochemistry 35(1):68-74.
Johnson, R.N. et al. (Jan. 1999). “Analytical Error of Home Glucose Monitors: A Comparison of 18 Systems,” Annals of Clinical Biochemistry 36(1):72-79.
Johnson, R.N. et al. (2001). “Error Detection and Measurement in Glucose Monitors,” Clinica Chimica Acta 307:61-67.
Kumetrix, Inc. (Dec. 1999). “Painless Blood Glucose Monitoring, Courtesy of the Mosquito,” Start-Up pp. 27-28.
Lee, S-C. (Jun. 1999). “Light Scattering by Closely Spaced Parallel Cylinders Embedded in a Finite Dielectric Slab,” Journal of the Optical Society of America A 16(6):1350-1361.
McGarraugh, G. et al. (2001). “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Therapeutics 3(3):367-376.
McNichols, R.J. et al. (Jan. 2000). “Optical Glucose Sensing in Biological Fluids: An Overview,” Journal of Biomedical Optics, 5(1):5-16.
Mahler, R.J. et al. (1999). “Clinical Review 102, Type 2 Diabetes Melitus: Update on Diagnosis Pathophysiology, and Treatment,” The Journal of Clinical Endocrinology and Metabolism 84(4):1165-1171.
Medline Plus. (Jun. 17, 2008). , Medical Encyclopedia, Monitor Blood Glucose-Series: Part 1-4, 6 pages.
Neeley, W.E. et al. (1981). “An Instrument for Digital Matrix Photometry,” Clinical Chemistry 27(10):1665-1668.
Neeley, W.E. (1983). “Reflectance Digital Matrix Photometry,” Clinical Chemistry 29(6):1038-1041.
Neeley, W.E. (1983). “Multilayer Film Analysis for Glucose in 1-μL Samples of Plasma,” Clinical Chemistry 29(12):2103-2105.
Neeley, W.E. (1988). “A Reflectance Photometer with a Square Photodiode Array Detector for Use on Multilayer Dry-Film Slides,” Clinical Chemistry 34(11):2367-2370.
Otto, E. et al. (2000). “An Intelligent Diabetes Software Prototype: Predicting Blood Glucose Levels and Recommending Regimen Changes,” Diabetes Technology and Therapeutics 2(4):569-576.
Pfohl, M. et al. (2000). “Spot Glucose Measurement in Epidermal Interstitial Fluid—An Alternative to Capillary Blood Glucose Estimation,” Experimental and Clinical Endocrinology & Diabetes 108(1):1-4.
Princen, H.M. (May 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, I. Capillary Rise Between Two Cylinders,” Journal of Colloid and Interface Science 30(1):69-75.
Princen, H.M. (Jul. 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, II. Capillary Rise in Systems with More Than Two Cylinders,” Journal of Colloid and Interface Science 30(3):359-371.
Rebrin, K. et al. (Sep. 1999). “Subcutaneous Glucose Predicts Plasma Glucose Independent of Insulin: Implications for Continuous Monitoring,” American Journal of Physiology 277(3):E561-E571.
Rosen, S. (1999). “Road to New-Age Glucose Monitoring Still Rocky,” Diagnostic Insight, pp. 4-5, 12-13, 16.
Smart, W.H. et al. (2000). “The Use of Silicon Microfabrication Technology in Painless Glucose Monitoring, ”Diabetes Technology & Therapeutics 2(4):549-559.
Svedman, C. et al. (Apr. 1999). “Skin Mini-Erosion Technique for Monitoring Metabolites in Interstitial Fluid: Its Feasibility Demonstrated by OGTT Results in Diabetic and Non-Diabetic Subjects,” Scand. J. Clin. Lab. Invest. 59(2):115-123.
Trinder, P. (1969). “Determination of Glucose in Blood Using Glucose Oxidase with an Alternate Oxygen Acceptor,” Annals of Clinical Biochemistry 6:24-28.
Yum, S. I. et al. (Nov. 1, 1999). “Capillary Blood Sampling for Self-Monitoring of Blood Glucose,” Diabetes Technology & Therapeutics, 1(1):29-37.
Extended European Search Report dated Jun. 16, 2014, for EP Application No. 09758787.7, filed on Jun. 8, 2009, 6 pages.
Final Office Action dated May 8, 2012, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 7 pages.
Final Office Action dated Apr. 30, 2013, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 10 pages.
Final Office Action dated Mar. 27, 2014, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 10 pages.
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 9 pages.
International Search Report dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003441, filed on Jun. 8, 2009, 2 pages.
International Search Report dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003445, filed on Jun. 8, 2009, 2 pages.
International Search Report dated Nov. 14, 2011, for PCT Application No. PCT/US2011/001132, filed on Jun. 24, 2011, 2 pages.
International Search Report dated Oct. 15, 2014 for PCT Application No. PCT/US2014/043516, filed on Jun. 20, 2014, 2 pages.
Non-Final Office Action dated Nov. 23, 2011, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 6 pages.
Non-Final Office Action dated Mar. 2, 2012, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 7 pages.
Non-Final Office Action dated Jun. 22, 2012, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 8 pages.
Non-Final Office Action dated May 30, 2013, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 9 pages.
Non-Final Office Action dated Jun. 13, 2014, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 8 pages.
Non-Final Office Action dated Jan. 13, 2015, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 12 pages.
Restriction Requirement dated Jul. 19, 2011, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 6 pages.
Written Opinion dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003441, filed on Jun. 8, 2009, 10 pages.
Written Opinion dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003445, filed on Jun. 8, 2009, 4 pages.
Written Opinion dated Nov. 14, 2011, for PCT Application No. PCT/US2011/001132, filed on Jun. 24, 2011, 6 pages.
Written Opinion dated Oct. 15, 2014 for PCT Application No. PCT/US2014/043516, filed on Jun. 20, 2014, 5 pages.
Final Office Action dated Sep. 30, 2015, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 16 pages.
Non-Final Office Action dated Jun. 25, 2015, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 7 pages.
Non-Final Office Action dated Jul. 8, 2015, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 13 pages.
Brazzle, J. et al. Active Microneedles with Integrated Functionality, Solid-State Sensor and Actuator Workshop, Hilton Head Island, South Carolina, Jun. 4-8, 2000, Technical Digest, 199-202.
Burge, M.R., (Aug. 2001). “Lack of Compliance with Home Blood Glucose Monitoring Predicts Hospitalization in Diabetes”, Diabetes Care 24(8): 1502-1503.
Extended European Search Report dated Apr. 19, 2011, for EP Application No. 10 18 0848.3 filed Sep. 28, 2010, 5 pages.
Extended European Search Report dated Feb. 22, 2012, for EP Application No. EP 10 18 1155, filed Sep. 28, 2010, 6 pages.
Extended European Search Report dated Jan. 22, 2013, for EP Application No. 12182900.6, filed on Sep. 29, 2006, 6 pages.
Extended European Search Report dated Apr. 29, 2013 for EP Patent Application No. 12192620.8, filed on Nov. 14, 2012, 8 pages.
Extended European Search Report dated Nov. 8, 2016, for EP Application No. 16 167 087.2, filed on Aug. 3, 2012, 6 pages.
Extended European Search Report dated Jan. 20, 2017, for EP Application No. 14 813 126.1, filed Jun. 20, 2014, 8 pages.
Final Office Action dated Jul. 9, 2008, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 19 pages.
Final Office Action dated Nov. 23, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 20 pages.
Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 7 pages.
Final Office Action dated Aug. 15, 2013 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages.
Final Office Action dated Apr. 13, 2016, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 31 pages.
Final Office Action dated Aug. 28, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 11 pages.
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 9 pages.
Final Office Action dated Jan. 22, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Final Office Action dated Jun. 30, 2010, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 11 pages.
Final Office Action dated May 30, 2007, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 11 pages.
Final Office Action dated Nov. 1, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 9 pages.
Final Office Action dated Nov. 21, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages.
Final Office Action dated Jun. 11, 2010, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 16 pages.
Final Office Action dated Mar. 10, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 24 pages.
Hemmerich, K.J. et al. (Apr. 1995).“Guide to Engineering Thermoplastics,” Medical Devices and Diagnostic Industry pp. 39-59.
International Search Report dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 3 pages.
International Search Report dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 1 page.
International Search Report dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 1 page.
International Search Report dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 1 page.
International Search Report dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 4 pages.
Integ. (2000). “LifeGuide™ Glucose Meter. No Lancets. No Blood,” located at <http://www.integonline.com>, last visited May 1, 2000, 10 pages.
Ishii H. et al., (Aug. 2001). “Seasonal Variation of Glycemic Control in Type 2 Diabetic Patients”, Diabetes Care 24(8):1503.
Massey V. et al. (Aug. 1960). “Studies on the Reaction Mechanism of Lipoyl Dehydrogenase” Biochim. Biophys. Acta 48: 33-47.
Non-Final Office Action dated Dec. 12, 2007, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 13 pages.
Non-Final Office Action dated Apr. 28, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 21 pages.
Non-Final Office Action dated Jun. 4, 2010, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 23 pages.
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,592, filed Aug. 3, 2011, 7 pages.
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,603, filed Aug. 3, 2011, 6 pages.
Non-Final Office Action dated Nov. 26, 2012 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 9 pages.
Non Final Office Action dated Apr. 8, 2015, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages.
Non Final Office Action dated Apr. 12, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 7 pages.
Non Final Office Action dated Aug. 5, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Non Final Office Action dated Dec. 5, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages.
Non Final Office Action dated Jan. 12, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated Jul. 13, 2010, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 11 pages.
Non Final Office Action dated Jul. 31, 2015, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 16 pages.
Non Final Office Action dated Mar. 21, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages.
Non Final Office Action dated Mar. 25, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 13 pages.
Non Final Office Action dated Mar. 5, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages.
Non Final Office Action dated May 14, 2008, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated May 16, 2013, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Non Final Office Action dated May 5, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 8 pages.
Non Final Office Action dated Nov. 2, 2006, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 10 pages.
Non Final Office Action dated Oct. 14, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 10 pages.
Non Final Office Action dated Oct. 3, 2008, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 10 pages.
Non-Final Office Action dated Dec. 17, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 6 pages.
Non Final Office Action dated Dec. 2, 2004, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 8 pages.
Non-Final Office Action dated Jan. 27, 2009, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages.
Non-Final Office Action mailed on Jan. 6, 2014, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages.
Non-Final Office Action dated Jun. 21, 2013, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 12 pages.
Non- Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages.
Non-Final Office Action dated Oct. 9, 2014, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 15 pages.
Non-Final Office Action dated Sep. 29, 2004, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages.
Notice of Allowance dated May 3, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 12 pages.
Notice of Allowance dated Mar. 27, 2015, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages.
Notice of Allowance dated Apr. 18, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages.
Notice of Allowance dated Apr. 19, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages.
Notice of Allowance dated Aug. 3, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages.
Notice of Allowance dated Jan. 14, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages.
Notice of Allowance dated Jun. 29, 2012, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 5 pages.
Notice of Allowance dated Mar. 14, 2012, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages.
Notice of Allowance dated Mar. 31, 2005, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages.
Notice of Allowance dated May 15, 2008, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 7 pages.
Notice of Allowance dated May 28, 2009, for U.S. Appl. No. 29/300,933, filed May 30, 2008, 6 pages.
Notice of Allowance dated Nov. 23, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages.
Notice of Allowance dated Nov. 27, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages.
Notice of Allowance dated Nov. 29, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 6 pages.
Notice of Allowance dated Oct. 12, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages.
Notice of Allowance dated Feb. 23, 2015, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 8 pages.
Notice of Allowance dated Feb. 5, 2014, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 9 pages.
Notice of Allowance dated Jun. 15, 2009, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 6 pages.
Notice of Allowance dated Mar. 2, 2016, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages.
Notice of Allowance dated Mar. 28, 2005, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 6 pages.
Notice of Allowance dated Jan. 26, 2017, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 7 pages.
Sonntag, O. (1993). Ektachem. Dry Chemistry, Analysis With Carrier-Bound Reagents, Elsevier Science Publishers, 57 pages.
Spielman, a. et al. (2001). Mosquito: A Natural History of Our Most Persistent and Deadly Foe, First Edition, Hyperion, New York, NY, 3 pages. (Table of Contents Only).
Straub F.B. (Mar., 1939). “Isolation and Properties of a flavoprotien from Heart Muscle Tissue”, Biochemical Journal 33: 787-792.
U.S. Precision Lens, Inc. (1983).The Handbook of Plastic Optics.
Written Opinion dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 4 pages.
Written Opinion dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 5 pages.
Written Opinion dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 6 pages.
Written Opinion dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 4 pages.
Written Opinion dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 7 pages.
Final Office Action dated Feb. 8, 2017, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 11 pages.
Clarke, W.L. et al. (1981). “Evaluation of a New Reflectance Photometer for Use in Home Blood Glucose Monitoring,” Diabetes Care 4(5):547-550.
Restriction Requirement dated Sep. 29, 2011, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 6 pages.
Restriction Requirement dated Dec. 22, 2011, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 6 pages.
Tietz, N.W. (1986).Textbook of Clinical Chemistry, W. B. Saunders Company, pp. 1533 and 1556.
Extended European Search Report dated Jul. 18, 2013, for EP Application No. 06 772 943.4, filed on Jun. 13, 2006, 7 pages.
Extended European Search Report dated Aug. 27, 2012, for EP Application No. 09 758 789.3, filed on Jun. 8, 2009, 13 pages.
Extended European Search Report dated Oct. 27, 2016, for EP Application No. 11 798 518.4, filed on Jun. 24, 2011, 7 pages.
Final Office Action dated Jan. 20, 2016, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 10 pages.
Final Office Action dated May 5, 2016, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 11 pages.
Final Office Action dated Aug. 12, 2016, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 18 pages.
Final Office Action dated Oct. 15, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 13 pages.
Final Office Action dated Aug. 14, 2012, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Final Office Action dated Sep. 23, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
International Search Report dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 1 page.
Non-Final Office Action dated Mar. 19, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages.
Non-Final Office Action dated Sep. 1, 2010, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages.
Non-Final Office Action dated Sep. 13, 2011, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Non-Final Office Action dated Feb. 28, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 12 pages.
Non-Final Office Action dated Apr. 10, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Non-Final Office Action dated May 29, 2015, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 13 pages.
Notice of Allowance dated Sep. 18, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 9 pages.
Notice of Allowance dated Feb. 16, 2016, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 7 pages.
Written Opinion of the International Searching Authority dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 3 pages.
Final Office Action dated Jun. 12, 2018, for U.S. Appl. No. 15/499,821, filed Apr. 27, 2017, 12 pages.
Notice of Allowance dated May 18, 2009, for U.S. Appl. No. 29/300,934, filed May 30, 2008, 4 pages.
Non-Final Office Action dated Mar. 20, 2019, for U.S. Appl. No. 15/499,821, filed Apr. 27, 2017, 12 pages.
Non-Final Office Action dated Mar. 27, 2019, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 8 pages.
Notice of Allowance dated May 15, 2019, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 8 pages.
Notice of Allowance dated Feb. 4, 2019, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 9 pages.
Final Office Action dated Nov. 25, 2019, for U.S. Appl. No. 15/499,821, filed Apr. 27, 2017, 13 pages.
Extended European Search Report dated Feb. 26, 2020, for European Application No. 19196465.9, filed on Jun. 8, 2009, 6 pages.
Wikipedia (2016). “Capillary action,” 7 pages.
Non-Final Office Action dated Dec. 16, 2016, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages.
Final Office Action dated Sep. 21, 2017, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 14 pages.
Non-Final Office Action dated Mar. 20, 2017, by the United States Patent and Trademark Office for U.S. Appl. No. 15/191,434, filed Jun. 23, 2016, 20 pages.
Non-Final Office Action dated May 15, 2017, by the United States Patent and Trademark Office for U.S. Appl. No. 14/743,867, filed Jun. 18, 2015.
Notice of Allowance dated Aug. 18, 2017, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 10 pages.
Non-Final Office Action dated Mar. 21, 2017, for U.S. Appl. No. 15/177,041, filed Jun. 8, 2016, 11 pages.
Non-Final Office Action dated Sep. 29, 2017, for U.S. Appl. No. 15/499,821, filed Apr. 27, 2017, 10 pages.
Final Office Action dated Nov. 29, 2017, for U.S. Appl. No. 15/177,041, filed Jun. 8, 2016, 13 pages.
Final Office Action dated Mar. 28, 2018, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 13 pages.
Related Publications (1)
Number Date Country
20140376762 A1 Dec 2014 US
Provisional Applications (1)
Number Date Country
61838171 Jun 2013 US